Adherence to antiretroviral treatment in Zambia:  : a qualitative study of patients and health professionals’ views by Sanjobo, Nawa
 1
Adherence to antiretroviral treatment in Zambia: a qualitative 















University of Oslo 
Faculty of Medicine 
Institute of General Practice and Community Medicine 















Thesis submitted in partial fulfillment of the Master of Philosophy Degree in 





TABLE OF CONTENTS 
ACKNOWLEDGEMENTS ......................................................................................................................... 4 
LIST OF TABLES........................................................................................................................................ 5 
LIST OF MAPS ............................................................................................................................................ 5 
ABBREVIATIONS AND ACRONYMS..................................................................................................... 6 
ABSTRACT .................................................................................................................................................. 7 
CHAPTER 1: INTRODUCTION ............................................................................................................... 8 
1.1 BACKGROUND ................................................................................................................................. 8 
1.2 GLOBAL PERSPECTIVES OF ANTIRETROVIRAL TREATMENT .............................................. 8 
1.3 THE SITUATION IN ZAMBIA .......................................................................................................... 9 
1.4 COUNTRY PROFILE ....................................................................................................................... 11 
1.5 GEOGRAPHICAL LOCATION ....................................................................................................... 11 
1.6 POPULATION AND DEMOGRAPHIC CHARACTERISTICS ...................................................... 12 
1.7 ECONOMY ....................................................................................................................................... 12 
1.8 HEALTH SECTOR ORGANISATION AND MANAGEMENT...................................................... 12 
1.9 HEALTH CARE PROVIDERS ......................................................................................................... 14 
1.10 INSTITUTIONAL FRAMEWORK FOR DELIVERING ART IN ZAMBIA................................. 14 
1.11 POLICY AND TREATMENT GUIDELINES ................................................................................ 16 
1.12 RATIONALE OF THE STUDY ...................................................................................................... 17 
1.13 AIM OF STUDY.............................................................................................................................. 19 
1.14 SPECIFIC OBJECTIVES................................................................................................................. 19 
CHAPTER 2:  LITERATURE REVIEW AND THEORETICAL FRAMEWORK............................ 20 
2.1 THE NOTION OF ADHERENCE ...................................................................................................... 20 
2.2 IS NON - ADHERENCE A PROBLEM?............................................................................................ 21 
2.3 SERVICE RELATED FACTORS ..................................................................................................... 22 
2.4 PATIENT AND TREATMENT RELATED FACTORS ................................................................... 23 
2.5 SOCIO-ECONOMIC AND CULTURAL RELATED FACTORS.................................................... 24 
2.6 RESEARCH CHALLENGES............................................................................................................ 24 
2.7 MEASURING ADHERENCE........................................................................................................... 25 
CHAPTER 3:  METHODOLOGY ........................................................................................................... 28 
3.1 METHODOLOGY AND APPROACH ............................................................................................. 28 
3.2 STUDY SETTING............................................................................................................................. 29 
3.3 KITWE DISTRICT............................................................................................................................ 31 
CHIMWEMWE URBAN  HEALTH CENTRE................................................................................................... 33 
NDEKE URBAN  HEALTH CENTRE............................................................................................................. 33 
KITWE CENTRAL HOSPITAL...................................................................................................................... 34 
3.4 MASAITI DISTRICT ........................................................................................................................ 35 
FIWALE HILLS  MISSION  RURAL HEALTH CENTRE .................................................................................. 36 
MISHIKISHI MISSION  RURAL  HEALTH CENTRE....................................................................................... 37 
3.5 MY POSITION IN THE FIELD ........................................................................................................ 37 
3.6 STUDY POPULATION .................................................................................................................... 38 
RECRUITMENT OF PARTICIPANTS AND PRE-TESTING OF INSTRUMENTS ................................................. 38 
SAMPLE SELECTION.............................................................................................................................. 39 
3.7 FOCUS GROUP DISCUSSIONS...................................................................................................... 40 
FOCUS GROUP DISCUSSIONS IN KITWE .................................................................................................. 40 
FOCUS GROUP DISCUSSIONS IN MASAITI ............................................................................................... 42 
3.8 IN-DEPTH INTERVIEWS................................................................................................................ 45 
IN- DEPTH INTERVIEWS IN KITWE ......................................................................................................... 45 
 3
3.9 INCLUSION CRITERIA................................................................................................................... 46 
3.10 EXCLUSION CRITERIA................................................................................................................ 47 
3.11 DATA COLLECTION AND MANAGEMENT.............................................................................. 47 
3.12 SECONDARY SOURCES OF DATA............................................................................................. 48 
3.13 DATA ANALYSIS.......................................................................................................................... 48 
3.14 VALIDITY AND RELIABILITY OF DATA.................................................................................. 48 
3.15 LIMITATIONS OF THE STUDY ................................................................................................... 50 
3.16 ETHICAL APPROVAL AND CONSIDERATIONS...................................................................... 50 




RESULTS ................................................................................................................................................ 56 
DISCUSSION .......................................................................................................................................... 63 
CONCLUSION ........................................................................................................................................ 65 
COMPETING INTERESTS...................................................................................................................... 66 
AUTHORS’ CONTRIBUTIONS.............................................................................................................. 66 
ACKNOWLEDGEMENTS ...................................................................................................................... 66 
REFERENCES......................................................................................................................................... 67 
CHAPTER 5: RECOMMENDATIONS................................................................................................... 74 
1. RECOMMENDATIONS TO GOVERNMENT AND POLICY MAKERS............................................ 74 
2. RECOMMENDATIONS TO THE HEALTH CARE SYSTEM (IMPLEMENTING INSTITUTIONS) . 75 
3. RECOMMENDATIONS TO PATIENTS AND THE COMMUNITY.................................................... 76 
REFERENCES .............................................................................ERROR! BOOKMARK NOT DEFINED. 






















I would like to acknowledge my sponsors, the Norwegian Agency for Development 
Cooperation (Norad) for making it possible for me to undertake the Master of Philosophy 
Degree in International Community Health at the University of Oslo. I am grateful to the 
Association of Heart and Lung Patients in Norway (LHL) for financial support during my 
fieldwork, their support made it easier for me to solve some of my logistical problems.  
I am also grateful to my supervisors Jan C Frich and Atle Fretheim for their guidance and 
in put to this work. Your hard work right from the conception of this piece of work, 
insights into the topic, literature review, research methods and general writing techniques 
have necessitated the completion of this work and adequately equipped me with skills to 
meet future professional challenges. Special thanks go to the teaching staff in the section 
of International Community Health, particularly Gunnar Bjunne, Johanne Sundby and 
Aktar Hussein for laying the foundation in International Community Health discourse on 
which this work firmly stands. To Vibeke and Ragnhild, your administrative skills and 
experience added value to our student lives. 
I would like to acknowledge my employers, the Copperbelt University for giving me an 
opportunity to pursue this training, particularly Mr Allan Ilunga and Dr Oscar O 
Simooya. Special thanks go to the Copperbelt Health Education Project who have been 
my collaborators in this study for the logistical support given to me during fieldwork, 
particularly Mr Alick Nyirenda and Mr Isaac Mumba. 
I am indebted to the people I met in the field from Kitwe and Masaiti districts whose 
ideas constitute this work. Acknowledgements are due to Mary Malipilo, Joseph Mumba 
and Moses Kamaloni for being enthusiastic and diligent Research Assistants. 
To my dear wife Marjorie, thank you for being there for me all the time even during 
times of uncertainties. I am motivated by your ability to manage multiple responsibilities. 
You mean a lot in my life. Our children Nawa, Mutonga and Mwanamwali, you can now 
expect dad’s companionship after his ‘beneficial absence’ at school. To my dad and 
mum, brothers, sisters, nieces, nephews, in-laws and friends too many to itemise, May I 
simply say thank you for your encouragements. Lastly, I thank the Lord almighty for 
keeping me healthy during my stay in Norway. 
 5
 
LIST OF TABLES                                                                                                Page 
 
Table 1: Summary of existing health facilities in Zambia………………………..14 
Table 2: Recommendations for ART in adults and adolescents in Zambia……....17 
Table 3: Characteristics of participants…………………………………………...71 















LIST OF MAPS                                                                                                  Page 
 
Map 1: Zambia and her neighbours……………………………………………..11 
Map 2: Copperbelt Province showing districts……………………………….....30 
Map 3: Kitwe district showing study sites……………………………………    31 




















ABBREVIATIONS AND ACRONYMS 
 
AIDS                Acquired Immune Deficiency Syndrome 
 
ART                 Anti Retroviral Therapy 
 
ARV                 Anti Retroviral 
 
CBoH               Central Board of Health 
 
CHAZ              Churches Health Association of Zambia 
 
CHEP               Copperbelt Health Education Project 
 
DHMT             District Health Management Team 
 
FGD                 Focus Group Discussion 
 
GFATM           Global Fund to Fight AIDS, Tuberculosis and Malaria 
 
HAART           Highly Active Antiretroviral Therapy 
 
HIV                  Human Immuno - deficiency Virus 
 
IEC                  Information, Education and Communication  
 
MoH                 Ministry of Health 
 
NGO                Non Governmental Organization 
 
OPD                 Out Patients Department 
 
STD                  Sexually Transmitted Disease 
 
UNAIDS          Joint United Nations Programme on HIV/AIDS 
 
WHO              World Health Organization 
 












Adherence to antiretroviral therapy (ART) is important for effective treatment. Little is 
known about barriers and facilitators to ART in Zambia. The aim of the study was to gain 
knowledge about adherence to antiretroviral treatment among patients and health care 
professionals in Zambia, in order to identify interventions that may be efficient in 
increasing patients’ adherence to antiretroviral treatment. 
Methods:  
I conducted a qualitative study in Kitwe and Masaiti districts on the Copperbelt Province 
of Zambia in 2006. I used a combination of in-depth individual interviews and focus 
groups with patients on ART, health care professionals working in ART clinics and other 
informants. The material was analysed using qualitative methods. 
Results:  
My study identified barriers and facilitators which were diverse in nature and belonged to 
a wide spectrum of factors which include patient related, health service related, socio-
economic and cultural factors. These include lack of communication and information 
about ART, inadequate time during consultations, follow up and counselling, 
forgetfulness, stigma, discrimination and disclosure of HIV status, lack of confidentiality 
in the treatment centres, lack of nutritional support, feeling better, prospects of living 
longer, family support, information about ART, support for income generating activities 
and transport.. 
Conclusion:  
This study suggests a multiplicity of factors and issues which need to be taken into 
consideration when providing ART. Further research is needed including participant 
observations to capture the actual interactions between patients and their health care 
providers. Also, future studies should assess the magnitude of non adherence to ART in 
Zambia using quantitative measures. My findings can inform the design of interventions 




CHAPTER 1: INTRODUCTION 
1.1 BACKGROUND 
 
The last two decades, HIV/AIDS has continued to spread across all continents causing 
the death of millions of adults in their prime age, disrupting and impoverishing families 
and turning millions of children into orphans. HIV/AIDS affects the most productive 
segments of the populations, and the epidemic has thus tremendously reduced workforces 
and reversed many years of economic and social progress and has in some cases posed 
threat to political stability. According to the Joint United Nations Programme on 
HIV/AIDS (UNAIDS), there were about 39.5 million people living with HIV by the end 
of 2006. Out of these, 37.2 million were adults and 2.3 million were children below the 
age of 15 years. There were 4.3 million new infections in 2006 (1) . In Sub – Saharan 
Africa about 2.8 million people were infected with HIV and 24.7 million people were 
living with HIV. Despite recent improved access to antiretroviral treatment (ART) and 
care in many of the world’s regions, the epidemic claimed 2.9 million lives in 2006 (1). 
In 2001, Heads of States and Representatives of Governments met at the United Nations 
General Assembly Special Session and issued a declaration of commitment to ensure a 
comprehensive and effective global response to the epidemic. The 2001 declaration 
endorsed care, support and treatment for people suffering from HIV/AIDS (2). 
1.2 GLOBAL PERSPECTIVES OF ANTIRETROVIRAL TREATMENT 
 
The advent of potent Anti Retroviral Treatment (ART) in 1996 led to a revolution in the 
care of patients with AIDS in the developed world. Although this treatments is not 
curative and also presents new challenges with respect to side effects and drug resistance, 
it  has dramatically reduced rates of morbidity and mortality, have improved the quality 
of life of people with HIV/AIDS and have revitalized communities (3) Moreover, 
HIV/AIDS is now perceived as a manageable chronic illness rather than as a plague  (4). 
Unfortunately, most of the 39.5 million people currently living with HIV/AIDS reside in 
developing countries and do not share this improvement in  prognosis (3). 
There has been a dramatic change in the global HIV/AIDS landscape with increased 
attention to care, treatment and support. On the World AIDS Day 2003, World Health 
Organization (WHO) and UNAIDS launched an initiative that aimed to treat 3 million 
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people in the world’s 50 heavily burdened countries by the end of 2005, called the “3 by 
5 initiative”. WHO estimated that at the end of 2003, some 6 million people in 
developing countries were in immediate need of life sustaining ART. However, only 
400,000 people received treatment over a third of them in Brazil. At the UN General 
Assembly High Level Meeting on HIV/AIDS on 22nd September 2003, WHO declared 
that the lack of access to HIV treatment was a global health emergency  (5). The last 
years there has been an increase in the number of countries scaling up ART programmes 
in developing countries due to increased resources from local governments and the donor 
community in initiatives like the Global Fund to Fight HIV/AIDS, Tuberculosis and 
Malaria, World Bank and the United States President’s Emergency Plan for AIDS Relief. 
1.3 THE SITUATION IN ZAMBIA 
 
Zambia is one of the countries with the highest prevalence of HIV in the world. The 
Zambia Demographic and Health Survey (ZDHS) of 2002 found that the prevalence 
among adults aged 15 – 49 years was 16 %. The mode of transmission is predominantly 
heterosexual. Mother to Child transmission is also significant. The peak in AIDS cases 
among women is 20 – 29 years and among men is 30 – 39 years old, suggesting 
transmission from older men to younger women. The prevalence of HIV is significantly 
higher among women (18%) than men (13%). Women account for 54% of all individuals 
living with HIV/AIDS in Zambia (6). The epidemic is estimated to have left at least 
600,000-orphaned children  (7).  
             In 1986 the government established the National AIDS Prevention and Control 
Programme, which focused on eight operational areas namely Tuberculosis and Leprosy, 
Information, Education and Communication (IEC), Counseling, Laboratory support, 
Epidemiology and Research, Sexually Transmitted Diseases (STD) and Clinical care, 
Programme management and Home based care (7). Zambia has adopted a multisectoral 
approach to prevention and mitigation of the HIV/AIDS epidemic. All Government 
sectors are involved in the response and so is the private sector, Non Governmental 
Organizations (NGOs), Community Based Organizations (CBOs), Church Organizations 
and the community at large. In 2002, the Zambian Government took a policy decision to 
make ART widely available to everyone needing treatment and allocated 3 million USD 
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to purchase ARV drugs for 10,000 people, to be provided through the public service. The   
Provision of ART was recognized as an integral component of the multisectoral response 
to HIV/AIDS. This was provided on a cost-sharing basis. In July 2005, the Ministry of 
Health started providing free treatment to people eligible for ART. The ART programme 
has been scaled up from the two initial pilot hospitals to 72 public health facilities across 
the country. The new policy includes free drugs, basic laboratory tests and CD4 counts  
(8) The goal of the ART Program is to reduce HIV related morbidity and mortality 
through universal access to ART for people living with advanced HIV infection in order 

























Source: Central Statistical Office, Lusaka, 2006  
 
1.5 GEOGRAPHICAL LOCATION 
 
Zambia is one of the countries in Southern Africa. It shares boarders with the Democratic 
Republic of Congo and Tanzania in the north, Malawi and Mozambique to the east, 
Zimbabwe and Botswana to the south, Namibia in the south-west and Angola in the west. 
It lies between 8 and 18 degrees south of the Equator and between 20 and 35 degrees east 
of the Greenwich Meridian. Zambia is landlocked, covering an area of 752,612 square 
kilometers (about 2.5% of Africa’s total surface area). Zambia is divided into nine 




1.6 POPULATION AND DEMOGRAPHIC CHARACTERISTICS  
 
Zambia has a young population of 10.3 million people. About 65% of the population 
lives in rural areas. Fertility rate is 2.9 children and annual growth rate of the population 
is 2.9%. By the age of 18, almost half of women aged 15 to 49 have had their first birth. 
Almost 50% of the population is less than 20 years of age, the most vulnerable to HIV 
(6). The population by sex is evenly distributed with women accounting for 50%. Zambia 
is a country endowed with many languages. Officially, there are 72 ethnic groups with 
each of them speaking a dialect of the seven major language cluster groups. English is the 
official language of instruction in schools, although there are other languages taught in 
schools in specific provinces. A large segment of the population remains uneducated and 
illiterate. In the census of 2000, only 55.3% of the population aged 5 years and above (6).  
1.7 ECONOMY  
 
Zambia has a mixed economy, with mining being at the centre stage of economic 
activities. In recent years, the Government has put agriculture and tourism as other 
important economic activities. Zambia is abundantly endowed with minerals and other 
natural resources that are required to stimulate economic development. Notwithstanding 
this, about 87% of the population lives below the income poverty line of $2 per day and 
about 64% live below the national poverty line of $1.08 per day.  It is also estimated that 
49% of the entire population are undernourished. In the 2006 Human Development Index 
Ranking, the country with a GDP per capita of $877 was ranked 165 out of 177 countries 
(9). 
1.8 HEALTH SECTOR ORGANISATION AND MANAGEMENT 
 
Since 1992 Zambia has been implementing health sector reforms, aimed at improving 
health service delivery and the health status of the population. The vision of the reforms 
has been to “ provide the people of Zambia with equity of access to cost effective, quality 
health care as close to the family as possible“ (10). The underlying principle of these 
reforms was decentralization of health service delivery through the delegation of key 
management responsibilities from the centre to the district and hospital levels. 
Decentralization also aimed at shifting resources from the centre to operational levels, 
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where healthcare delivery services were conducted. The reforms also emphasized the 
importance of community participation in the management of health services and the 
need for a well motivated and remunerated work force. Implementation of the reforms 
has been through a series of National Health Strategic Plans, of which the country is in its 
fourth plan covering the period 2006 – 2011 (10). In this respect, two parallel, but 
complimentary organizational structures were introduced, namely the popular structures 
for public involvement and participation in the decision – making process, and the 
technical and management structures, designed to ensure that health services were 
implemented and managed in a manner that was technically sound and conformed with 
best practices.  The popular structures created in that process included: the Central Board 
of Health (CBoH) board, at national level; Hospital Management Boards, at hospital 
level; District Health Boards, at district level; and the Neighborhood Health Committees 
and Health Centre Committees, at community level. 
                The technical structures that were established included: the Management 
Teams at Ministry of Health (MoH) and CBOH, at national level; Hospital Management 
Teams, at hospital level; and District Health Management Teams, at district level. 
Further, the Provincial Health Medical Offices were reconstituted into Provincial Health 
Offices. There has been a recent repeal of the National Health Services Act (NHSA 
2005), leading to the dissolution of CBoH, Hospital and District Management Boards. 
Following this decision, the health sector is undergoing a comprehensive restructuring 
process through which the functions of MOH and CBOH have been merged and the 
management and control of all the public health facilities and services now fall directly 
under MOH through the Provincial Health Offices. In order to ensure continued popular 
public participation in the management of health services, the hospital and district 
management boards are in the process of being replaced by advisory councils. Despite 
this vision, the health sector is still facing significant challenges including the high 
disease burden, compounded by the HIV/AIDS epidemic. The performance against the 
Millennium Development Goals has not been satisfactory. The country has one of the 
highest dependency ratios in the world and is also among the most urbanized countries in 
Sub – Saharan Africa, with approximately 36% of the population living in urban areas.  
Poverty levels have remained high, estimated at 68 % in 2006 (9). As a result of high 
 14
levels of poverty, preventable and treatable diseases have taken an enormous toll on the 
poor, increasing pressure on the already constrained health sector.  
1.9 HEALTH CARE PROVIDERS 
 
Health care in Zambia is provided by government institutions, the Churches Health 
Association of Zambia (CHAZ), mining companies, Parastatal organizations, private 
clinics and traditional healers. The structure of public health facilities run by the 
government comprises health posts as the smallest unit, health centers, level one 
hospitals, level two hospitals and level three hospitals (11). 
 
Table 1: Summary of existing health facilities in Zambia 
Type/level Government Mission Private Total 
Hospitals 53 27 17 97 
Health Centers 1052 61 97 1210 
Health Posts 19 0 1 20 
Total 1124 88 115 1327 
Source: CBoH, Health Institutions in Zambia: A listing of Health Facilities according to 
levels and locations, 2002 (11). 
 
 
1.10 INSTITUTIONAL FRAMEWORK FOR DELIVERING ART IN ZAMBIA 
 
Administration of ART is being integrated into the existing national health care system 
(12). ART is part of the essential health care package with components that are being 
delivered at all levels of the health system. The various levels, stakeholders and 
institutions involved in the delivery of ART include the following: 
 
District Health System – The District Health System provides primary health services at 
the district level, preventive and health promotion services and clinical services. The 
following levels of health care provision are at the district level, the district hospital 
(level 1 hospital), Health Centre, and Health post. At the Community level NGOs, 
 15
Community Based Organizations, the Church, Community Based Distributors and 
Traditional Birth Attendants supplement health delivery. 
 
Private Sector – Private sector plays a significant role in providing medical services in 
Zambia. Private for profit health services are mainly concentrated in urban areas. The 
private sector includes private clinics and hospitals, private pharmacies and companies 
which provide health services to a greater or lesser extent to their employees who require 
ART. 
 
Hospital Management Boards – These provide health services through large public 
hospitals that are outside the district health system. Included here are second and third 
levels hospitals. The second level hospitals provide clinical services in Pediatrics, 
Internal Medicine, Obstetrics and Gynecology and General Surgery as well as advanced 
diagnostic services. This level receives referrals from and provides technical support to 
the district level. It conducts training for health workers. These are located at regional 
level. Under the authority of the Hospital Management Boards, five hospitals have been 
identified to provide tertiary services. These hospitals provide specialized services in 
clinical disciplines including Pediatrics, Internal Medicine, Obstetrics and Gynecology, 
general Surgery, radiology, specialized laboratory as well as other specialized diagnostic 
services. The Copperbelt province has three of such hospitals.  
 
Ministry of Health – MOH provides majority of all health services in Zambia. It 
interprets and implements health policies develop guidelines, including treatment and 
preventive protocols, monitor performance of health facilities through provincial health 
offices, ensure steady flow of drugs, medical and non medical supplies. The MOH also 
retains the functions of resource mobilization, policy formulation, strategic planning and 
bilateral and multi lateral international cooperation. 
 
National HIV/AIDS/STI/TB Council – This oversees policy interpretation and 
implementation, coordination of HIV/AIDS/STI/TB activities, donor and stakeholder 
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coordination, resource mobilization and disbursement and monitoring and evaluation of 
HIV/AIDS/STI/TB programmes and activities. 
 
Medical Council of Zambia – is responsible for overall quality of medical practice in 
the country including the quality of medical facilities. This includes accreditation of 
health facility to ensure that all facilities that are providing ART provide the services 
within the minimum required standards. The Medical Council of Zambia certifies health 
care providers of HIV care and ART services. 
 
National Food and Nutrition Commission – National Food and Nutrition Commission 
is responsible for providing nutritional support guidelines and implementation of 
nutrition based interventions. 
1.11 POLICY AND TREATMENT GUIDELINES 
 
The goals of ART in Zambia include reducing the amount of HIV viruses in the body, 
support and helping the immune system, improving the quality of life, reducing HIV 
related illness and deaths and reducing the risk of HIV transmission to others. Provision 
of ART is based on the following criteria; must be HIV infected, must meet clinical and 
laboratory criteria of symptoms, viral load and CD4 count, must understand the potential 
side effects and the importance of strict adherence (13). The Zambian government has 
since August 2005 been offering free ART to the people which is accessed through the 
public health institutions. This decision was arrived at as a result of the overwhelming 
poverty levels on the other hand and the high cost of accessing ART on the other hand. 
The National ART programme adopted the WHO Public Health Approach treatment 
guidelines for resource limited settings. Zambia has adopted standard multi drug 
regimens in order to help minimize the emergence of drug resistance among the patients 
(13). The guiding principles for provision of ART according to government are as 
follows: 
• ART will be provided free in all public health facilities 
• Registration fees will still be applicable 
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• Free services in this context shall include all aspects of ART including 
Antiretroviral drugs, laboratory services and tests like Full Blood Count, Liver 
Function tests, Total Lymphocyte Count, CD4 Cell Count, Rapid Plasma Reagin 
test, Sputum examination and other related services. 
• Refugees shall have free access to ART 
• Foreign nationals, excluding refugees shall pay full cost for ART 
 
Table 2 lists the recommendations for initiating ART in Zambian adults and adolescents: 
 
Table 2. Recommendation for ART in adults and adolescents in Zambia 
Clinical Stage CD4 Available CD4 Not available 
I CD4 Guided Do not treat 
II CD4 Guided Total Lymphocyte Count 
less than 1,200 mm3 
III Consider CD4 Count Treat 
IV Treat Treat 
Source: Scaling up Antiretroviral Treatment for HIV/AIDS in Zambia. Policy and 
Operational Guidelines. Ministry of Health; Ndeke House; Lusaka; 2004. 
 
When CD4 Cell Count is below 200 mm3, treatment should be initiated irrespective of 
the clinical stage. Again if the CD4 Cell Count drops between the levels of 200mm3 to 
350mm3, consideration for treatment should be done if there is more than one sign, 
before the CD4 count drops down below 200. When the CD4 count is above 350 mm3, 
treatment should be postponed if the patient is not showing any symptoms. 
1.12 RATIONALE OF THE STUDY 
 
Adherence or compliance with therapy is one of the most complex areas of ART 
management. While the development of resistance to ART is regarded as the greatest 
threat to our current armamentarium of drugs, poor adherence, which is the major cause 
of the development of resistance, is given little attention in planning an antiretroviral 
programme (14). Adherence to ART is well recognized to be an essential component of 
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individual and programmatic treatment success (15). Studies of drug adherence in the 
developed world have suggested that higher levels of drug adherence are associated with 
improved virological and clinical outcomes and that rates exceeding 95% are desirable in 
order to maximize the benefit of ART (16).  
Access to ART has become feasible in developing countries due to reduced costs of 
antiretroviral drugs and increased resource allocation by various governments and other 
initiatives. There has been fears from the developed countries of wide spread, unregulated 
access to antiretroviral drugs in Sub Saharan Africa which could lead to rapid emergence 
of resistant viral strains, spelling doom for individual patients, curtailing future treatment 
options and leading to transmission of resistant strains. While there were few skilled 
Physicians in the use of antiretroviral drugs, the health infrastructure was incapable of 
monitoring viral load, immune status, or side effects of the drugs. Drug procurement and 
distribution systems were said to be weak and drug interruptions were likely. There were 
no monitoring systems in place to check on drug adherence or drug effectiveness (17).  
                    It is estimated that there are 100,000 new infections of HIV in Zambia 
annually. At least 99,000 people die of AIDS related deaths annually in Zambia (18). 
HIV/AIDS affects the most productive age group required for economic development, 
and has impacted negatively on all sectors of national development and has reversed 
developmental gains achieved by the country since independence. Zambia has embarked 
on a massive scaling up programme for ART. According to the Central Board of Health , 
the number of people accessing ART in the last two years has increased by over eight 
fold from 3,000 in 2003 to over 43,771 by the end of 2005 (19). HIV/AIDS treatment 
scaling up is a priority according to the National HIV/AIDS/TB/STD Strategic Plan (20). 
                   A recent report from a study conducted at the University Teaching Hospital 
in Lusaka has raised concern about the emergence of resistant HIV strain to first line 
ART regimen in Zambia (21). Because adherence of patients with HIV to ART is 
essential for both clinical effectiveness and public health, research in adherence to ART 
in Zambia is critical. Little is known about factors that influence adherence and non 
adherence to ART in the Zambia. Zambia offers free treatment to her patients and the 
treatment support is largely supported by funds from the donor community and therefore, 
the emergency of resistant strains to the first line treatment is a serious development 
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which will make the sustainability of the programme not only more costly but a public 
health challenge.  
1.13 AIM OF STUDY 
 
The aim of the study was to gain knowledge about adherence to antiretroviral treatment 
among patients and health care professionals in Zambia, in order to identify interventions 
that may be efficient in increasing patients’ adherence to antiretroviral treatment. 
1.14 Specific Objectives 
 
• To investigate how health care professionals explain adherence and non 
adherence to antiretroviral treatment in patients. 
• To investigate how patients who are on antiretroviral treatment explain adherence 
and non adherence to antiretroviral treatment. 
•  To identify factors that can inform interventions to increase patients’ adherence 
















 CHAPTER 2:  LITERATURE REVIEW AND THEORETICAL FRAMEWORK  
2.1 THE NOTION OF ADHERENCE 
 
There is no universally accepted definition of medication adherence. With respect to 
HIV/AIDS care specifically, adherence to HIV medication has been defined by Jani  as 
“the ability of the person living with HIV/AIDS to be involved in choosing, starting, 
managing and maintaining a given therapeutic combination medication regimen to 
control viral (HIV) replication and improve immune function” (22). The term adherence 
has also been defined as ‘the extent to which a person’s behaviour (in terms of taking 
medications, following diets, or executing life style changes) coincides with medical or 
health advice’ (23).   
                      However, Trostle et al. suggests that behavior often labeled ‘non compliant’ 
by physicians can be seen as reasonable attempts by patients to manage their illness 
outside the examination room (24). Non compliance from the patient’s perspective is 
often rational, understandable and justifiable given that social forces unrelated to the 
biomedical model influence his or her behavior. Trostle argues that much of the literature 
on non compliance emphasizes the medical profession’s conviction that the problem lies 
in the patient’s behavior or in the doctor - patient relationship (24) .The evident disparity 
between patient’s needs and the physician’s professional interests coincides with much 
speculation about the power of the biomedical establishment, especially it’s power to 
legitimate concepts of health and illness and to configure the patient’s subjectivity. 
According to Conrad , most theories locate the sources of non compliance in the doctor – 
patient interaction, patient knowledge or beliefs about treatment and to a lesser extent, the 
nature of the regimen or illness (25). Conrad offers an alternative perspective on non- 
compliance with drug regimens, one situated in the patient’s experience of illness. Using 
data from a study of experience of epilepsy, Conrad argues that from a patient centered 
perspective, the meanings of medication in people’s everyday lives are more salient than 




2.2 IS NON ADHERENCE A PROBLEM?  
 
Antiretroviral drug resistance is a major challenge to treatment programmes for both 
developed and developing countries. Currently, approximately 10% of new HIV – 1 
infection in the United States of America and Europe involve viral strains exhibiting 
resistance to at least one drug (26). According to WHO, only 50% of patients who suffer 
chronic diseases like HIV/AIDS, diabetes and hypertension adhere to treatment 
recommendations (27). In developing countries, when taken together with poor access to 
medicines, poor adherence is threatening to render futile any effort to tackle chronic 
conditions such as HIV/AIDS. Of those patients suffering from HIV/AIDS, 
approximately one-third take their medication as prescribed. Studies of HIV/AIDS have 
reported low adherence rates, similar to those seen for other chronic diseases. Sub 
optimal adherence rapidly leads to resistance, which can then be transmitted to other 
people (28,29).The potent and new combinations of ARV agents, known as Highly 
Active Antiretroviral Therapy (HAART), have proven efficacious in reducing viral load 
and improving clinical outcomes. However, the large number of medications involved, 
the complicated dosing requirements and the sub optimal tolerability make adherence 
difficult (27). Studies of ART in developing countries show that there is already 
resistance circulating among patients who are starting their first line ‘official’ course of 
therapy (21) . In a study to assess the level of compliance to ART among AIDS patients 
in Nigeria, only 54% of the patients took at least 80% of the drugs prescribed. Main 
reasons for non-adherence to medication include non-availability of the drugs, 
forgetfulness and lack of funds  (30). A study conducted in South Africa showed 
excellent adherence in a high proportion of HIV – 1 infected adults receiving ART in a 
resource limited setting. Despite the low socio – economic status and the low to mid 
levels of education attainment of the study population, 88% reported ART adherence >95 
% (31). 
             In Zambia, a recent laboratory study conducted at the University teaching 
hospital, Lusaka had confirmed the drug resistant strain, and its emergence is clearly an 
indication that people are not being consistent with their medication (21). An unpublished 
operations research report by the International HIV/AIDS Alliance in conjunction with 
Horizons Project on a pilot intervention for HAART in Lusaka and Ndola Central 
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Hospitals found that information on ART at the start of treatment was not adequate, 
patients adjusted and devised their own routines and reminders of pill taking, fear of 
organ damage were identified as some of the reasons for non adherence to ART (32). 
Non-adherence can take many forms. The patient may simply fail to fill the prescription. 
If the prescription is filled, the patient may incorrectly time the medication or take wrong 
dose because he or she misunderstood or forgot the health professional’s instructions. 
Patients may also forget a dose completely or prematurely terminate the medication. 
Moreover, patients may self adjust their regimen because of side effects and toxicity or 
personal beliefs (27). Reviews of HIV/AIDS medication regimen adherence literature 
have chiefly focused on a variety of factors which include characteristics of the 
medication regimen, social factors, psychological, patient- provider relationship, 
treatment regimen, disease and clinical setting (33). 
2.3 SERVICE RELATED FACTORS 
 
Patient adherence to ART is a complex phenomenon that can be affected by a number of 
variables. Some studies suggest that good health care provider-patient relationships are 
associated with better adherence. Patient education, especially towards understanding the 
medication regimen and its requirements is probably the chief health care provider 
influence towards better adherence (34). Good communication between patient and 
health care provider about patient’s life style and preferences can improve ART 
adherence (35,36). The cost of treatment has also been identified as a barrier to 
adherence, leading to extended drug holidays. Cost was a barrier that prevented 
medication purchase, therefore, interfered with adherence or self imposed drug holidays 
(37,38). Some studies conducted in developing countries have documented non 
availability of drugs in health facilities as a contributing factor to non adherence to ART 
(30,39). Inadequate knowledge about how to take medication has been recognized as a 
barrier to patient adherence to ART. Patients do not adhere to their treatments because of 





2.4 PATIENT AND TREATMENT RELATED FACTORS 
 
The complexity of adherence to ART by patients has been documented as a daunting 
challenge to adherence interventions. Reconciling medication schedule with demands of 
shift work has been identified as a barrier to adherence (40). Industrial and health 
workers in particular, were identified in other studies as often facing a moving work 
schedule where work, eating and sleep times changed frequently. Fitting together the 
demands of timing several different medications with meal times, sleep and in some 
cases, highly regimented work, where little time flexibility is permitted on the job, creates 
cross-cutting pressures that pose barriers to adherence and generate conditions for 
forgetting (41). Concurrent use of a substance while taking ART leads to patients not 
adhering to their medications (42-44). Substance abusers were least likely to cope well 
with other demands in their lives. They experienced low self-esteem, low sense of control 
over their lives and fatalism about HIV and life in general. Such patients had impaired 
ability to adhere to medications (44). 
            Side effects of ART have been identified to cause adherence problems in patients. 
Patients experienced side effects like nausea, fatigue, diarrhoea and vomiting, tingling 
and as such made medication intake difficult (45). Side effects have consistently been 
associated with decreased adherence and patients who experienced more than two 
aversive reactions were less likely to continue with their treatment. The literature on side 
effects clearly show that optimal adherence occurs with medications that remove 
symptoms, where as adherence is reduced by medications that produce side effects 
(46,47).  
            Dose adjusting by patients to suit their daily schedules has been documented to be 
a barrier to adherence. A common shift of a three times a day to a two times a day pattern 
has been identified in patients taking ART (40). Some studies found that patients who 
were on twice daily doses or less reported better adherence and were more likely to take 
their medications when away from home (48,49). 
Other studies have shown that some patients avoided taking their medications at work 
due to short term side effects which other people might observe like nausea, feeling tired 
and sluggish (50). 
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The hustles and demands on medication regimens in form of number of pills that have to 
be taken, the size and taste of pills, the frequency of dosing and how the normalcy of 
daily life can “get in the way” and interfere with adherence (40,44). 
           Depression or negative mood states is a recurring factor associated with adherence 
in literature. The emotional trauma experienced when dealing with issues of chronicity 
and uncertainty associated with HIV/AIDS diagnosis and treatment plan has been 
identified to contribute to non adherence to ART (42,45,51). 
2.5 SOCIO-ECONOMIC AND CULTURAL RELATED FACTORS 
 
Fear of other people knowing or noticing patients taking ART or the effects of 
medications may lead to others guess about their illness. Patients instead, resort to taking 
their medications in secrecy or avoid situations exposing their status (42,52). Taking 
medications may ‘out’ infected individuals. Such concerns arise in different settings, 
particularly at work and other public environments. Even in the confines of one’s own 
home, one’s status could be inadvertently disclosed to others. As a result, many try to 
hide medications and adopt dosing schedules and routines to conceal their pill taking as 
well as their diagnosis from others, which can cause adherence stress (50). Disclosure of 
HIV status or HAART may result in antagonism from others who hold negative attitudes 
and beliefs about HAART, potentially impeding adherence (50). Stigma has been 
identified in literature as a factor hindering patient adherence to ART. Patients talk about 
the difficulties of taking medications in public because they do not want anyone to know 
about their status (53). In other studies, the cost of medication has been associated with 
lack of patient adherence, leading to extended drug holidays (37). Social supports for 
medication adherence plays a critical role in supporting patients adhere to their 
medications. Patients whose families offered no or erratic supports have difficulties in 
adhering to their medication schedules (36). 
 
2.6 RESEARCH CHALLENGES 
 
Assessing adherence poses numerous challenges. It is easy for health workers to miss 
adherence problems because patient self-reports of adherence tend to be exaggerated 
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(54,55) due perhaps both to a recall bias and a desire to please the provider and avoid 
criticism. In addition to misreporting of adherence by patients, estimates of adherence 
made by health care providers are also usually over optimistic (56). Adherence to HIV 
medications is an extremely complicated process that includes both the drugs themselves 
and the adjustments to daily life necessary to provide the pre-requisite conditions for 
effective drug therapy (46). 
2.7 MEASURING ADHERENCE 
 
Research on adherence has been hampered by the absence of a convenient means of 
measurement. Various objective methods are available, but each has significant practical 
limitations: their objectivity and sophistication rises in parallel with cost and difficulty in 
administration (57). The lack of a gold standard to measure adherence and the dynamic 
nature of medication taking behaviours further complicate adherence assessments and 
interventions and highlight the need for additional research in these areas (58). 
Adherence to therapy is difficult to measure accurately. The most common methods used 
are pill counts, reviews of pharmacy records, self reporting and use of electronic 




Patient self report represents a simple and relatively inexpensive way of measuring 
adherence, yet it often overestimates it. Frick and colleagues, for example, documented 
88% adherence to ART via self report versus 66% via Medication Event Monitoring 
System (MEMS)  (59). Similar findings have been reported by others, and overall, self 
reported adherence fails to identify 20% to 30% of non adherent patients (60). Self report 
assessments are mainly performed using non standardized questionnaires/surveys and 
include recall of adherence over a specific time frame (2-3 days, 7 days, 1 month). A 3 to 
7 day recall has been shown to be more closely related with viral load suppression than 
longer periods of time (61). In research setting, the patient medication adherence 






A number of studies have shown that Clinicians are poor estimators of adherence, yet 
national guidelines emphasize that they should use their estimate of treatment adherence 
when initiating ART in asymptomatic HIV infected persons (63,64). According to Helene 
Hardy, most clinicians in busy settings have to predict patient’s adherence rather than 
thoroughly assess it. This might ultimately result in the withholding of ART from a 
patient estimated to adhere poorly to therapy and to be at risk for viral resistance. On the 
other hand, overestimation of adherence may be more common among clinicians who 
have increased familiarity with a patient and in whom they may limit efforts to detect 




Pill count represents another method available to measure adherence to ART. It often 
overestimates adherence because of the well known problem of “medication dumping” 
(65,66). Pill counts are of limited use in clinical practice because they are time 
consuming, not well suited for a busy outpatient setting, computationally complex and 




Review of pharmacy records can be used to measure adherence to therapy, particularly in 
settings where pharmacy records are entirely computerised (58). However, they do not 
provide evidence that the medication doses are taken appropriately and can sometimes 
lead to misinterpretation of usage when dosages change and/ or when patients receive 
ART during a stay in acute or long-term care facilities (67). Gaps in pharmacy refills are 
likely to indicate poor adherence to ART; however, it is more difficult to assume good 
adherence when timely pharmacy refills are present because receipt of the drug is not a 





Medication Event Monitoring System (MEMS)  
 
MEMS are pill bottles with caps containing an electronic chip that records each time the 
bottle is open. The information is downloaded onto a computer and analysed to determine 
degrees of adherence and patterns of timing and pill consumption. MEMS have been 
extensively used in HIV adherence research and have been shown to provide adherence 
measures that closely correlate with viral suppression (49;68). MEMS provide an 
objective measure of pill bottle opening, pattern of adherence, accuracy of timing of 
doses, and a computerized way to measure adherence. Malfunction or loss of the 
electronic cap can occur and lead to irretrievable adherence assessments. However, the 





















CHAPTER 3:  METHODOLOGY  
3.1 METHODOLOGY AND APPROACH  
 
It has been widely documented in literature that there is no single method or approach 
that can be said to be more important than others, as seen from the contextual relevance 
and application. Research literature has shown that the purpose of the study determines 
the methods that can be used for data collection (69,70).  
                  The two research method categories have been stated as either quantitative or 
qualitative. Denzin and Lincoln (71), in explaining the difference between qualitative and 
quantitative researchers, explain that qualitative researchers stress the socially 
constructed nature of reality, the intimate relationship between the researcher and what is 
studied and the situational constraints that shape the inquiry- seeking answers to the 
questions that stress how social experience is created and given meaning, while in 
contrast, quantitative studies emphasize the measurement and analysis of casual 
relationships between variables, not process inquiry is purported to be within a value free 
framework (71). Creswell (72),  explains that quantitative research focuses on the cause 
and effect of a phenomenon, uses measurements and observations, employs strategies of 
inquiry such as experiments and surveys and collects data on predetermined instruments 
that yield statistical data. Alternatively, qualitative research is one in which the inquirer 
makes knowledge claims based on multiple meanings of individual experiences, social 
meanings and historically constructed, with an intent of developing a theory or pattern. It 
is further stated that one of the chief reasons for conducting a qualitative study is 
exploratory. Exploring sensitive issues is better articulated through interaction that is 
found in qualitative inquiry. The lived experiences and meanings of peoples’ lives are 
better explored through a qualitative study. Such an interaction offers an opportunity to 
capture the individual’s point of view, examine their every day life constraints and 
securing of rich descriptive data. However, the concerns of a qualitative study, as 
assumed by various scholars include, among others, primarily with process rather than 
outcomes or products; more interest in meaning, researcher is the primary instrument for 
data collection and analysis; involves field work – observing and recording behaviour in 
natural settings; study is descriptive; process is inductive in that researcher builds 
abstractions, concepts, hypothesis and theories from detail. Qualitative methods are 
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useful for the study of human and social experience, communication, thoughts, meaning, 
attitude, and processes, especially related to the interactions, relations, development, 
interpretation, movement and activity of people (73). However, the insignificant size of 
the sample in qualitative studies cannot allow the generalization of the findings to get a 
representative picture.  
             To investigate adherence to antiretroviral treatment in Zambia, I decided to 
undertake a qualitative research study. I chose a qualitative approach because the aim of 
the study was to gain an understanding of the holistic picture of factors surrounding 
adherence and non adherence to antiretroviral treatment among health care professionals 
and patients taking antiretroviral treatment and living in both urban and rural 
communities of Kitwe and Masaiti districts. Given the nature of this study, the use of in-
depth interviews and focus group discussions (using interview guides with open – ended 
questions) with purposely selected participants was appropriate. In order to derive 
detailed information and useful insights, the depth and breath of investigating a 
phenomenon like that of lived experiences of patients taking ART, and the complexities 
of providing ART in resource limited settings would require the use of qualitative 
approach. Most studies examining factors associated with adherence have been 
conducted with quantitative surveys. Despite the multitude of studies conducted and the 
numerous factors identified, no single variable or combination of variables is sufficiently 
consistent to apply to any individual or group of people. Qualitative studies can enrich 
our understanding of the complex and multifactorial nature of the determinants of 
adherence and non adherence. 
3.2 STUDY SETTING 
 
The study was conducted in Zambia on the Copperbelt Province. The Copperbelt 
Province has one of the highest numbers of HIV/AIDS cases in the country, estimated at 
22.1%. It also has a good number of patients accessing ART, estimated at 9,873 by the 
end of 2005 (12). The population of the Copperbelt is estimated to be around 1,581,221 
people (74). Copper, which is the mainstay of the nation’s economic activities, is 
produced on the Copperbelt Province. In Kitwe, data was collected from health facilities 
namely Chimwemwe Clinic, Ndeke Clinic and Kitwe Central Hospital. In Masaiti, data 
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was collected from Fiwale Hills Mission Rural Health Centre and Mishikishi Mission 
Rural Health Centre. 
 
Map of the Copperbelt Province 
 
Source: Central Statistical Office, Lusaka (2006) 
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3.3 KITWE DISTRICT 
 






Kitwe district is located on the Coperbelt Province of Zambia and covers a radius of 737 
square kilometres. It shares boarders with Chingola on the north, Mufulira in the north-
east, Luanshya in the south and Kalulushi in the west. It is the second largest city on the 
Copperbelt Province and third in the country. Kitwe has a tropical climate and vegetation 
with temperatures ranging from 18 - 36 degrees Celsius. Kitwe is located in the centre of 
the province.  
            According to the Census of population and Housing of 2000, Kitwe had an 
estimated population of 410,448, with a population density of 557 persons per square 
kilometre. The population growth rate for the district is 2.2%. The main economic 
activity in the district is copper mining, which employs about 51% of those in formal 
employment. The Government and Private sector employ the remaining 49% of those in 
formal employment (74). Kitwe is among the few towns in Zambia exhibiting economic 
growth after the privatisation era. A good percentage of the population are not engaged in 
meaningful economic activities. The prevalence of HIV in the district is 26.6% (6). The 
district has 19 Government run clinics and one public hospital. The district has two 
privately run hospitals, one by the mining company and the other one by some new 
investors. It also has 22 clinics and surgeries run by private institutions. There were four 
government institutions offering ART and a number of private ones at the time of this 
study. There were 4,317 patients accessing ART through the public health system at the 
same period. The district runs two parallel ART programmes, one being coordinated at 
the DHMT and the other at the district’s tertiary government hospital at Kitwe Central 
Hospital. The district has over 75 doctors, over 400 nurses, and over 100 paramedical 
staff. The district has one training institution for Registered nurses and midwives. The 
district receives its drugs and laboratory supplies from the Medical Stores Limited, which 
is a government institution mandated to procure drugs and supplies on behalf of all 
government institutions. Tuberculosis which is an opportunistic infection in people 
suffering from AIDS is among the top three diseases causing high mortality to the 
population of Kitwe. About 60% of the population have access to safe drinking water 




 Chimwemwe Urban Health Centre 
 
Chimwemwe Urban Health Centre is located in Chimwemwe township of Kitwe district. 
It is about 8 kilometres from the town centre and 1 kilometre off the road going to 
Chingola. The clinic caters for urban and peri-urban areas around the catchment zone. 
The clinic caters for a population of 43,489. The clinic offers both preventive and 
curative services to the community. The clinic refers its serious cases to Kitwe Central 
Hospital which is about 4.5 kilometres away from the centre. The clinic has 16 health 
workers consisting of nurses and paramedical staff. The clinic has no resident Medical 
Officer but has a visiting one on specific days. The health centre started offering ART in 
2005 and had over 300 patients on the treatment register at the time of data collection 
(75). The health facility has a laboratory but it has no capacity to do specialized tests like 
the CD4 Cell Count and Liver Function test. Patients on ART are examined and treated 
by the Medical Officer and Clinical Officer. The health centre has 5 staff trained in ART 
and had 6 counsellors who all participated in the programme. Even those officers who 
had not yet been trained in ART also participated in the programme. The health centre 
conducted the ART clinic twice per week. Many people in Chimwemwe are self 
employed.  
Ndeke Urban Health Centre 
 
Ndeke urban clinic is located right in Ndeke township of Kitwe. It is about 10 kilometres 
from the town centre. The clinic caters for an urban population drawn from Ndeke 
Township and the surrounding compounds. Ndeke is located in the south-eastern part of 
the district. The catchment’s population for the health centre is estimated at 41,684. The 
health centre offers both preventive and curative services to the community. The clinic 
refers its serious cases to Kitwe Central hospital which is 13.5 kilometres away from the 
health centre. The health centre has a total of 37 staff including nurses, paramedical and 
support staff. The health centre has no resident Medical Officer but visits the centre on 
specific days from the DHMT. The health centre started offering ART in 2005 and had 
over 250 patients on the treatment register at the time of data collection (75). The health 
facility does not offer specialized tests like CD4 count, Liver Function tests, and other 
highly specialized laboratory services. There were 3 Clinical Officers, 4 Nurses, 1 
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Laboratory Technician and a Dispenser involved in the ART programme. The health 
centre conducts ART clinics twice in a week. 
Ndeke has a fair road network linking it with other parts of the district. Most of the 
people in communities serviced by the health centre are not in formal employment but are 
self employed.  
 Kitwe Central Hospital 
 
Kitwe Central hospital is a third level regional referral hospital. It caters for the northern 
region covering Copperbelt, Luapula, Northern, and North-Western Provinces. The 
hospital provides specialized services in clinical disciplines including paediatrics, internal 
medicine, obstetrics and gynaecology, general surgery, radiology, specialized laboratory 
services including CD4 count, Liver function test and others. At a local level, the hospital 
draws its patients from all the townships in the district. The hospital is located in the 
north-western direction from the business centre and is about 3.5 kilometres away from 
the town centre. The hospital had 72 Medical Officers, 248 nurses, 11 Clinical Officers, 7 
physiotherapists, 3 pharmacists and 8 pharmacy technicians, 11 Laboratory technicians, 1 
Orthopaedic specialist, 13 radiographers, 9 Dental technicians, 2 nutritionists and 268 
support staff at the time of data collection. Tuberculosis was the first ranked cause of 
death at the health facility, with malaria and pneumonia ranking in the second and third 
places. There were 3,630 patients accessing ART at the hospital at the time of data 
collection. The hospital had 120 health care staff trained in ART (76). The hospital 
conducts ART clinics on Mondays, Tuesdays, Thursdays and Fridays. The hospital 
attended to about 100 patients on ART every day of the clinic on average. ART was 
coordinated through two committees at the hospital, namely the Adherence Committee 
and the ART Committee. The ART Committee comprised all heads of departments while 
the Adherence Committee comprised those involved with the daily contact with patients 
like Medical Officers, Clinical Officers, Nurses, Counsellors and Pharmacists. The 














Masaiti is one of the rural districts of the Copperbelt Province. It shares boarders with six 
other districts namely; Mpongwe, Luanshya, Ndola, Mkushi, Kapirimposhi, Lufwanyama 
and the Democratic Republic of Congo. Masaiti has an estimated population of 113,900 
people, with an annual growth rate of 2.6% The prevalence of HIV in Masaiti district is 
estimated at 11.3% (6). The district has 20 rural health centres scattered around the area.  
The main ethnic groups are the Lamba people. The majority of the people earn their 
living through subsistence farming. Masaiti has been having a steady increase in the 
number of HIV cases over the past years. The increase has been attributed to high poverty 
levels in the district, increased trading activities with the bordering city and municipal 
towns, the busy highways passing through the district( Ndola-Kapirimposhi/ Mpongwe-
Luanshya and Masangano-Luanshya) and traditional beliefs which still influence 
people’s perceptions of the disease. The District Director of health coordinates all the 
health activities in the district. The district has no hospital. For hospital referrals, patients 
are sent to St Theresa Mission hospital in Mpongwe district or Ndola Central hospital and 
Arthur Davison Children’s hospital in Ndola district. The district has one Medical officer 
who moves in all the 5 ART centres on specific days.  
 Fiwale Hills Mission Rural Health Centre 
 
Fiwale Hills Mission Rural Health Centre lies 32 kilometres south of Ndola. Fiwale lies 5 
kilometres east of Ndola-Kabwe highway. The centre covers an area of 600 square 
kilometres and is divided into 26 community neighbourhood health committees. The 
catchment’s population is estimated at 18,000. HIV prevalence rates are on the increase 
because of its location and high levels of poverty (77). The majority of the people in 
Fiwale are generally peasant farmers. Fiwale Hills Mission Rural Health Centre provides 
both preventive and curative services to the community. The centre provides health 
services like children’s clinics, family planning, antenatal care and HIV/AIDS/TB/STI 
care. The centre has about 100 patients on ART at the time of data collection. Fiwale 
started offering ART in 2005 (77). The ART programme is conducted twice in a week. 
The Medical Officer manages the patients. The centre does not have a resident Medical 
Officer or Clinical Officer. The health centre has a laboratory and pharmacy offering 
basic services. There were about 6 members of staff who were involved in the ART 
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programme. The centre gets it’s consignment of drugs from the DHMT. The centre has 
two programmes of ART, one being a pilot project under CHAZ and the government one. 
The centre does not do CD4 count tests and relies on Total Lymphocyte Count and the 
Clinical picture of the patient to commence them on treatment. 
Mishikishi Mission Rural Health Centre 
 
Mishikishi Mission Rural Health Centre lies 50 kilometres south of Ndola and about 70 
kilometres east of Kapirimposhi district in Central Province. The health centre is situated 
along the Ndola-Kapirimposhi highway. The catchment’s population of the centre is 
about 10,000 people scattered around the area. It’s social, economic and demographic 
characteristics are similar to those of Fiwale. It’s location along the main busy road 
network connecting the Coperbelt Province and other parts of the country make the area 
prone to HIV infection. Mishikishi caters for six other rural health centres in the district 
in ART services (77). Most of these clinics lie about 20-30 kilometres away from the 
main centre. The mode of transport communication for the majority of the population is 
by walking, with a few using bicycles. The health centre did not have a Medical Officer 
or a Clinical Officer. The ART programme was conducted once per week on Fridays by a 
visiting Medical Officer who is based at Masaiti DHMT offices. There were about 8 
health personnel at the health centre at the time of data collection. The centre has a 
laboratory and a dispensary offering basic services. The laboratory does not do CD4 
count and other specialized tests. There were 5 health personnel trained in counselling at 
the centre (77). Patients are referred to Ndola for further investigations and management. 
There was only one nurse trained in ART at the time of data collection.  
3.5 MY POSITION IN THE FIELD 
 
The researcher undertook the study in a region he has lived and worked for the past 16 
years. The researcher works for the Copperbelt University in the Health Services 
Department. The Copperbelt University Health Services provides primary health care 
services to the university community which comprise students, employees and their 
dependants. The department also provides health services to the nearby communities, 
especially in Child and maternal health, Tuberculosis and other general health services. 
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The Researcher has some experience in the management of chronic conditions like 
Tuberculosis and HIV/AIDS. The Researcher has also personal experience about the 
impact of HIV/AIDS at both family and community levels. During fieldwork, the 
researcher was identified by participants and gate keepers as a Researcher who had come 
to investigate adherence to antiretroviral treatment in the community. To avoid 
contradictions and suspicions, the researcher informed participants about his professional 
background. The Researcher and his assistants live in an environment and culture they 
were familiar with as that helped with communicating with the local people. The 
Researcher hails from a region which traditionally and culturally considered the study 
participants in Masaiti district as his “traditional cousins”. This is an important cultural 
identification in an African context and helps in making people feel relaxed and open up. 
There was no evidence of respondents giving responses either to please the researchers or 
saying what they thought we wanted to hear. Most of the patients and health care 
professionals seemed to have enjoyed the discussions and spoke freely. Laughing among 
themselves was a common phenomenon during the discussions, especially when 
discussing topics related to sex. While the researcher was keen to understand how the 
participants constructed their social lives, there was at no time any intimate and regular 
contacts established with the members of the groups studied.   
  
3.6 STUDY POPULATION 
Recruitment of participants and pre-testing of instruments 
 
Returning home in a capacity of a “Researcher”, my initial task was to apply for ethical 
clearance. This was granted by the Tropical Diseases Research Centre Ethical 
Committee. Following ethical clearance, I started the process of identifying Gatekeepers 
in the community in which the study was going to be conducted, who will lead the 
network of contacts. With the help of a local Non Governmental Organization (NGO) 
called Copperbelt Health Education Project (CHEP), several potential research assistants 
were identified and interviewed for possible engagement. CHEP has a network of human 
resource working with Community based organizations in the two districts. Three 
research assistants were selected for the study. A training programme was arranged for 
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them in theoretical, ethical and methodological issues of the research topic and data 
collection methods. After the assistants were recruited, the interview guide for patients 
was translated into the local languages of Bemba and Lamba. All the research assistants 
were involved in the translation process being indigenous people. The guides consisted of 
themes in line with research objectives. Out of the three assistants, one was a female and 
she participated in Kitwe district. Some of the desired attributes of the assistants included 
good inter personal /communication skills, native of the area, fluent in the local language, 
mature, self motivated, college education and willing to work with minimum 
remuneration. The background of the assistants was retired Teacher, Pastor and 
Coordinator of a community based organisation working in the area of HIV/AIDS. I had 
to recruit two assistants for Masaiti district because of the vastness of the district. The 
instruments were pre tested in two health centres which were not part of the study sites in 
both districts. Two focus group discussions were conducted during the pre-test of 
instruments over a period of two days and appropriate adjustments were made to the 
interview guides. The District Health Directors in the two districts of study were 
approached and formal application letters were written to them requesting their 
institutions to participate in the study. The District Directors in turn also introduced the 
researcher and his team to the Officers who were directly in-charge of the antiretroviral 
treatment programmes. In most of these sites these turned out to be doctors, clinical 
officers and nurses. Orientation meetings were held with these health professionals in 
order to ensure that they understood the whole purpose of the study. Participants were 
recruited through the health care professionals for both in-depth interviews and Focus 
Group discussions. After the recruitment of potential participants, the researcher had to 
arrange a series of meetings with the potential participants to explain in detail the whole 
purpose of the study and offer the would be participants an opportunity to ask questions 
about the study. 
Sample Selection 
 
Maximum variation which is a strategy of purposive sampling was used to identify 
participants for the study. Selection of information rich participants was preferred in 
order to learn more about the issues of central importance to the study (78). 
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3.7 FOCUS GROUP DISCUSSIONS 
 
Focus group discussions are group interviews with participants who are similar to each 
other in a way important to the researcher to provide qualitative data in a focused 
discussion to help understand the topic of interest. The nature of this homogeneity is 
determined by the purpose of the study. This similarity is the basis of recruitment, and 
participants are informed of these common factors at the beginning of the discussion. 
Focus groups comprise 5 – 10 people. The group must be small enough for everyone to 
have an opportunity to share insights and yet large enough to provide diversity of 
perceptions. According to Krueger and Casey (79), a focus group presents a more natural 
environment than that of an interview because participants are influencing and influenced 
by others, just as they are in life. The researcher serves several functions in the focus 
group discussion as a moderator, listener, observer and eventually analyst using an 
inductive process. Focus groups work particularly well to determine the perceptions, 
feelings, and thinking of the people about an issue. Focus group information can be used 
to design a large scale quantitative study. The intent of focus group is to promote self 
disclosure among participants.  
Focus group discussions in Kitwe 
 
 In Kitwe district, the researcher held three focus group discussions. The composition of 
the three groups was one male, one female and a mixed group. The mixed group was well 
represented with equal number of both men and women. These were drawn from the two 
participating urban health centres. The ages of the participants were between 31 and 47 
years, with an average age of 33 years. The group comprised people who were widows, 
widowers, married and single. The groups knew part of the participants whom they came 
together with from the same clinic. Most of the patients have been taking antiretroviral 
drugs for a period ranging from 5 months to 3 years. Most of the patients used to work 
before they became sick and at the time of the study, very few were engaged in gainful 
economic activities. However, the discussions were characterized by vigour to contribute 
as each participant wanted to share their own experiences. The groups exhibited openness 
throughout the discussions more so as seen from their differences in opinions about the 
subject matter. The third group which comprised both men and women was also drawn 
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from the same health centres. All the participating people were selected purposively by 
the health care professionals. The focus groups were held in the board room of CHEP’s 
Training Centre following a discussion which was held with the participants to choose 
the venue. Participants were informed about the dates for the discussions a week in 
advance. However, follow up contact through phone was maintained. The first discussion 
did not take off as earlier planned as participants came late. But an hour later the 
discussion started. The discussions were held on three different days with each group 
featuring on a specific day agreed upon by both parties. The venue was quite relaxed and 
provided for confidentiality during the discussions. The movement of the participants was 
arranged in a way that they find their way to the meeting place and then they were 
reimbursed for the transport expense they incurred. The researcher and his assistants had 
to introduce themselves to the participants before the discussions. The researcher also 
clarified the purpose of the study and what will be done with the data. He also informed 
participants about how their confidentiality will be protected in the data at all times 
during discussion, analysis and even publication. Quick rounds of introductions were 
done among participants so that they could form the beginning of relationship with other 
participants. The discussions lasted between one and half hours to two hours. All the 
discussions were tape recorded and supplemented by hand written notes. Refreshments 
were also served to the participants during the period of the discussions. Before 
participating into the study, the participants were made to understand what they were 
consenting to and verbal consent was given to the research team. During focus group 
discussions, participants sat in a circle so as to allow the researcher have eye contact with 
the participants and be in a position to observe non verbal communication among the 
participants. Only members of the discussion group were allowed to be present in the 
venue of the discussions. All the members of the groups were given a chance to 
participate in the group discussions. This was done in order to ensure that no participant 
dominated the discussion at the expense of other participants’ ideas or views. Ground 
rules were spelt out in order to foster freedom of discussion where everyone was free to 
express his or her opinions. Contribution during the discussions was as a way of raising a 
hand and each one was given a chance to talk. All the focus groups held in Kitwe were 
conducted in a local language known as Bemba and all the participants were fluent in the 
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language. Both the researcher and his assistant were fluent in the language. General 
introductions were done with the participants in order to make them feel relaxed before 
getting deep into the discussions. In these introductions participants mentioned where 
they stay, how long they have been on ART, distance from their home to the health 
centre, what they do for their living and their marital status. The role of the researcher 
and assistant in all these discussions was to ask questions to the participants, probe where 
there was need for follow up and listening to the unfolding lived experiences of the 
group. Before winding up the discussions, a recap of what had been discussed with the 
participant was done in order to ensure that the participants verified the information.  At 
the end of each discussion, the researcher met with the assistant to review the day’s 
discussions and made comments and observations. At the end of each day, the researcher 
took some time to listen to the tapes in order to hear if the recordings went well and to 
familiarise himself with the data. Data was entered the following day after each 
discussion by the research assistant.  
Focus group discussions in Masaiti 
 
A change in the initial research plan took place from Mpongwe to Masaiti following my 
securing a research grant from the Association of Heart and Lung patients of Norway 
(LHL). This was necessitated by the funding institution that was not operating in 
Mpongwe district. However, this did not affect the study objectives in anyway because 
the social and demographic characteristics of the two districts were the same. They are 
both rural districts having the same ethnic groups, living standards and economic 
activities. Following this development, an application to the Tropical Diseases Research 
Centre Ethical Committee was made for an amendment to the approved research 
protocol. Following the approval of the amendment, I approached the district Director of 
Health for introduction. The Director also introduced the research team to the Medical 
Officer in charge of the ART programme in the district. The Medical Officer was the one 
making contact with the health centres offering ART in the district. This was later 
approved and that was when the research team started collecting data from Masaiti 
district. In Masaiti, only two focus group discussions were conducted. However, the 
recruitment process was not short of difficulties. The initial attempt did not yield the 
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desired results as most of the potential participants failed to volunteer especially for the 
individual interviews. The explanations given by the health care professionals recruiting 
participants were that most of the potential participants expressed unwillingness to 
participate. Another issue that emerged from this interaction indicated that the political 
atmosphere which was obtaining at that particular time had an influence on their 
perception of the planned study. The potential participants claimed that they had been 
told by some politicians that some politicians were advocating withdrawing free ARVs 
when they came to power. This made the potential participants fear to express their views 
especially that they had not yet met the research team. Zambia was preparing for 
presidential, parliamentary and local government elections at the time of data collection. 
Therefore, initially the potential participants were not sure of the position of the 
researcher and his assistant until an orientation meeting was held with them to explain the 
purpose of the study. 
                   At Fiwale Hills Mission Rural Health Centre, a focus group was conducted 
with men. There were 10 participants drawn from around Fiwale area. The discussion 
was held in a shelter provided for by the health centre. This was a shelter which the 
health care professionals used also for mother and child health activities like 
immunisation talks, nutritional demonstrations, and family planning and antenatal care 
talks with the mothers in the community. The venue was agreed upon by both the 
participants and the research team. The environment was quiet, relaxed and conducive for 
a discussion without distraction from outside. The centre also acted as a neutral venue as 
most of the participants had to cover quite some distance to reach the heath centre. The 
ages of the participants were between 27 and 45 with the average being at 36. The group 
comprised people who were widowers, married and single. The participants were also 
recruited through the health care professionals. Ground rules were also spelt out in order 
for the group have a free and conducive atmosphere for discussion. Contribution was by a 
way of raising a hand and each participant was given an opportunity to make their 
contributions. The discussion was tape recorded and as well supplemented by hand 
written notes. The duration of the focus group discussion took about 2 hours. At this 
FGD, the research assistants facilitated the discussion while the principal researcher 
observed the participants’ group dynamics. The participants sat in a circle while they 
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were discussing and that allowed the researcher and his assistants to observe the group 
proceedings. The local language known as Lamba was used during the discussion. 
Participants were given transport re-imbursement to cover their local transportation. In 
total, they were given K25, 000.00 which translates to USD 5.00. Most of the participants 
spend about 4 hours to reach the health centre. At the end of the discussion, the research 
team had to go through what was discussed with the participants so as to verify the 
contents of the discussion. At the close of the meeting, participants were thanked for their 
efforts and were re-assured of confidentiality of the issues which they had discussed with 
the research team. 
                    The other rural focus group was conducted at Mishikishi Mission Rural 
health centre with a group comprising men and women. The total number of participants 
was 10, including 5 men and 5 women drawn from around Mishikishi area. The 
discussion was held in a ward which the centre used for isolating infectious diseases. This 
venue was decided by both parties after consideration of the other option which was 
available. The other option was the shelter outside which according to the participants 
was too open for a sensitive discussion of that nature. The range of the participants’ ages 
was between 29 and 47 years, with the average being 35 years. The venue was also 
viewed by the participants as being more central as most of the participants had to cover 
long distances to reach the health centre.  
                 The group comprised participants who were widows, widowers, married and 
single. The participants were also recruited through the health care professionals. Ground 
rules were also spelt out in order for the group have a free and conducive atmosphere for 
discussion. Contribution was by a way of raising a hand and each participant was given 
an opportunity to make their contributions. The discussion was tape recorded and as well 
supplemented by hand written notes. The duration of the focus group discussion took 
about 2 hours. At this FGD, the research assistants facilitated the discussion while the 
principal researcher observed the participant group dynamics. The participants sat in a 
circle while they were discussing and that allowed the researcher and his assistants to 
observe the group proceedings. The local language called Lamba was used during the 
discussion. Participants were given transport re-imbursement amounting to K25, 000 
(USD 5) to cover their local transportation. Most of the participants spend about 3 - 4 
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hours to reach the health centre. At the end of the discussion, the research team had to go 
through what was discussed with the participants so as to verify the contents of the 
discussion. Participants were thanked for their efforts and were re-assured of 
confidentiality of the issues which they had discussed with the research team.  
3.8 IN-DEPTH INTERVIEWS 
 
The purpose of a qualitative research interview is to obtain qualitative descriptions of the 
life world of the subject with respect to interpretation of their meaning using a semi 
structured guide. A guide has a sequence of themes to be covered, as well as suggested 
questions. Yet at the same time, there is openness to changes of sequence and forms of 
questions in order to follow up the answers given and the stories told by the subjects. 
The research interview is an interpersonal situation, a conversation between two partners 
about a theme. It is a specific form of human interaction in which knowledge evolves 
through a dialogue. The qualitative research interview attempts to understand the world 
from the subjects’ point of view, to unfold the meaning of people’s experiences, to 
uncover their lived world prior to scientific explanations. The qualitative research 
interview is a construction site of knowledge (80). 
In-depth interviews in Kitwe  
 
In-depth interviews were used as the main method of collecting data. In order to get a 
holistic picture of this study, interviews made the researcher understand the world from 
the study informants’ point of view. They told their life stories, their experiences and 
allowed the researcher to have a face to face conversation, which allowed for further 
questioning, probing and clarification of issues making the data collected rich and 
complete. All in- depth interviews with patients were held at Kitwe Central Hospital in 
Kitwe district. At the hospital, the Executive Director introduced the Researcher and his 
team to the Director of Clinical Services, who was in-charge of the ART programme. The 
Director clinical Services in turn introduced the Researcher to the Heads of out Patient 
Department (OPD) and Pharmacy for onward recruitment of staff participants. The 
participants included both men and women. The potential interviewees were met in their 
individual capacities for a briefing about the purpose of the study and thereafter, an 
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appropriate date was arranged with each participant. Participants were purposively 
selected by the health care professionals. Participants were drawn from different parts of 
the city. All the participants preferred the hospital venue for their interviews. They 
observed that the venue was most appropriate because there was no one who could 
become inquisitive or suspicious about their being at the hospital since they were patients 
who visited the hospital regularly. Individual written or verbal consent was obtained from 
each participant before the interview. The interviews were conducted in the adherence 
counselling room which was provided for this purpose by the hospital authorities. The 
office was located in the OPD and assured confidentiality. The office had two chairs and 
a table to be used by the researcher and the participant. In-depth interviews were 
conducted using semi structured interview guides for both patients and health care 
professionals. The interviews in most cases lasted about 60 minutes. All the interviews 
were tape recorded and supplemented by hand written notes. During in-depth interviews, 
both English and Bemba were used. The health care professionals preferred to be 
interviewed in English while most of the patients preferred the local Bemba language. At 
the end of the interview, each participant was thanked for their time and assured of 
confidentiality of the information shared. Before closing up the interview, a recap of what 
had been discussed with the participant was conducted in order to ensure that the 
participant verified the information. Each participant was given transport re-imbursement 
as a way of acknowledging their effort to the commitment and fulfilment of the interview 
obligation. At the end of each day, the researcher took some time to listen to the tapes in 
order to hear if the recordings went well and to familiarise himself with the data. Data 
was entered the following day after each discussion by the research assistant. 
3.9 INCLUSION CRITERIA 
 
• Men and women who have a confirmed HIV positive test result and were taking 
antiretroviral treatment. 
• They should not be too ill to participate in the study. 
• Aged between 20 – 49 years. For health care professionals the age was not very 
significant. However, gender proportions were taken into consideration. 
• Participants should be members of the study community. 
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• Willing to volunteer to participate. 
3.10 EXCLUSION CRITERIA  
 
• Patients who were too ill to participate. 
• HIV positive men and women who have not yet started taking antiretroviral 
treatment. 
• Patients who were below 20 and above 49 years. 
• Patients who had just started taking antiretroviral treatment at the time of the 
study. 
3.11 DATA COLLECTION AND MANAGEMENT   
 
For both group discussions and in-depth interviews, data was recorded using a tape 
recorder. Since focus groups were conducted by a facilitator and an observer, the 
observer also recorded the discussions manually. In order to overcome the problem of 
identifying individual speakers and the differentiation between statements of several 
speakers, participants were given numbers and the numbers were linked to the voices. A 
running order of the discussion was produced and involved listening to the taped 
discussions immediately after everybody left, in order to keep the voices of the 
participants alive in the researcher’s mind. On the same day of the interview/discussion, a 
back up copy was produced from the original copy. Each tape was labelled with a number 
for easy identification. The labels included; date of interview, participant category and 
participant identity number. After interviews the tapes were handed to the research 
assistants for transcriptions. Although some discussions were done in a language the 
researcher does not speak fluently, care was taken to minimize losses of data that would 
arise from translations and transcriptions. An independent transcriber and translator was 
engaged to help strengthen the information collected. In order to carefully compare data 
collected from the two methods employed in the study, semi structured interviews with 




3.12 SECONDARY SOURCES OF DATA 
 
Part of the information on government policies, guidelines on antiretroviral treatment and 
management was obtained from government documents.   The maps depicting the study 
areas were obtained from the Central Statistical Office in Lusaka. They were digitalized 
using the Geographical Information System (GIS) from the census maps used during the 
2001 tripartite election. 
3.13 DATA ANALYSIS 
 
Audiotapes of the interviews were transcribed in verbatim by the researcher and 
assistants and then translated from Bemba and Lamba local languages into English. The 
Researcher then read the transcripts independently and developed a coding frame for the 
analysis. The Researcher coded all the transcripts, and read independently the material. 
Material about participants’ perceived factors influencing ART adherence and non 
adherence were identified and used for systematic condensation, according to the 
principles of Giorgi’s phenomenological analysis (81) ,and modified by Malterud (73) . 
The analysis followed four steps: (i) reading all the material to obtain an overall 
impression and bracketing previous conceptions; (ii) identifying units of meaning 
representing different aspects of participants’ perceived factors influencing ART 
adherence, and coding for these units; (iii) condensing and summarising the contents of 
each of the coded groups; (iv) generalising descriptions and concepts concerning 
perceived factors influencing adherence and non adherence to ART. 
 
3.14 VALIDITY AND RELIABILITY OF DATA 
 
Validity is another word for truth. It refers to the extent to which the data collection 
strategies and instruments measure what they purport to measure. Reliability refers to the 
extent to which studies can be replicated. This is the degree of consistency with which 
instances are assigned the same category by different observers or by the same observer 




Efforts taken to strengthen and secure validity and reliability 
During data collection, there were factors that could have posed threats to validity and 
reliability of this study. Measures that were taken to secure validity and reliability are 
explained below in relation to identified possible threats. 
 
Pilot testing the interview guides 
Since the interview guides were developed in Oslo, pilot testing was essential to check on 
the clarity of questions, questioning techniques during the interviews and establishment 
of rapport. Discussions on pilot testing interviews were carried out with the informants 
and colleagues in the research team who indicated that the interview guides were serving 
the intended purpose.  
 
Interviewer as an instrument 
Another factor that could have threatened validity and reliability of the study was the 
status of the interviewer as an instrument. The pilot testing helped the interviewers to 
improve their questioning techniques. Efforts were made to overcome the threat by 
practicing. Listening to the tapes after the pilot testing and also after each interview 
helped the researcher overcome possible biases. During the interviews, the researcher and 
his assistants listened carefully to the informants’ answers and elaborations. The 
informants were given enough time to elaborate their answers with such remarks, ‘Do 
you have anything else you want to tell me.’ In addition, probes were used to obtain 
information. Consistency of information was checked by paraphrasing what the 
interviewees said, for instance, ‘If I get you well, you said…’ 
 
Use of independent transcriber  
To minimize on bias, after the interviewers transcribed and translated the interviews, an 
independent transcriber and translator went over the transcriptions thereby strengthening 
validity and reliability of data. The transcriber and translator listened to the interview 
tapes and compared with the transcribed interviews in order to identify possible 




Another strategy used to strengthen validity and reliability was the use of different 
sources of information. Data collected from patients and health care professionals from 
both urban and rural settings was supplemented with data collected from key informants. 
3.15 LIMITATIONS OF THE STUDY 
 
Results from this study can not be generalized to the whole population of Zambia. The 
results can not also be generalized to the whole Copperbelt Province because the sample 
was small. 
The study also relied solely on interview data. 
 
3.16 ETHICAL APPROVAL AND CONSIDERATIONS 
 
The project has been approved by the Regional Committee for Research in Norway and 
the Tropical Diseases Research Centre Ethical Committee in Zambia. Introductory letters 
were written to relevant institutions to participate in the study. The health care 
professionals approached the participants on behalf of the researcher. The objectives of 
the study were explained to all participants as well as the leaders of the bodies which 
represented the study subjects. Permission and informed consent was obtained without 
duress on the participants and participants had the right to withdraw from the study at any 
time. The Researcher asked for permission to tape record the focus group discussions and 
in-depth interviews so that it helped him capture accurately the participants’ insights in 
their own words. Participants were informed that they could request the tape recorder to 
be turned off at anytime if they were not comfortable with it. Participants were also 
informed that their names would not be used at any point. They were also informed that if 
they did not wish to participate in the study that would not affect their ability to access 
the usual services they currently received or expected to get from their health providers 
then and in future. The expected interview time was also discussed with the participants. 
Participants were given an opportunity to ask questions about the study before they 
committed themselves to participate They were also informed about the possibility of 
having the final version of the findings of the study at all the institutions that participated 
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in the study like the Ministry of health ,the Network of Zambian People living with 
HIV/AIDS and that the  results may also be used in further studies or as a contribution to 
the body of knowledge on adherence to antiretroviral treatment in Zambia.  
               The appropriateness of the language used to explain the purpose of the study 
and request for peoples’ informed consent was done in a way understood by the 
participants at all the times, and clarifications made to ensure that their decisions were 
informed. The information given by the respondents was treated in the strict confidence 
and would be used for the furtherance of the study objectives only. The true identity of 
the respondents was always held in confidence. Sensitivity to age, gender and cultural 
context was considered during the study. Needy communities have high expectations 
when involved in a study. The researcher explained with the help of the representatives 
from each affiliated institution about the importance of the study and the benefits in terms 
of more knowledge on adherence to antiretroviral treatment in communities. There were 
no promises of money or other resources made to participants. However, the researcher 
considered modest budgets for drinks, snacks and transport re-imbursements. The 
researcher took responsibility for data protection, together with the assistants while in the 
field. An opportunity to verify the information given by the participants during the 
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Adherence to antiretroviral therapy (ART) is important for effective treatment. Little is 
known about barriers and facilitators to ART in Zambia. The aim of this study was to 
explore patients’ and health care professionals’ perceived barriers and facilitators to 
adherence to ART in Zambia. 
Methods:  
We conducted a qualitative study in Kitwe and Masaiti districts in the Copperbelt 
Province of Zambia in 2006. We used a combination of in-depth individual interviews 
and focus groups with patients on ART, health care professionals working in ART clinics 
and other informants. The material was analysed using qualitative methods. 
Results:  
We identified barriers and facilitators which were diverse in nature and belonged to a 
wide spectrum of factors which include patient related, health service related, socio-
economic and cultural factors. These include lack of communication and information 
about ART, inadequate time during consultations, follow up and counselling, 
forgetfulness, stigma, discrimination and disclosure of HIV status, lack of confidentiality 
in the treatment centres, lack of nutritional support, feeling better, prospects of living 
longer, family support, information about ART, support for income generating activities 
and transport.. 
Conclusion:  
Our study suggests a multiplicity of factors and issues which need to be taken into 
consideration when providing ART. Further research is needed including participant 
observations to capture the actual interactions between patients and their health care 
providers. Also, future studies should assess the magnitude of non adherence to ART in 
Zambia using quantitative measures. Our findings can inform the design of interventions 





The term adherence has been defined as ‘the extent to which a person’s behaviour (in 
terms of taking medications, following diets, or executing life style changes) coincides 
with medical advice [1]. Antiretroviral medications have significantly improved the 
health and well being of many HIV patients [2]. Still, lack of strict adherence to highly 
active antiretroviral therapy (HAART) is considered to be one of the key challenges to 
AIDS care in the world. Estimates of average rates of non adherence to HAART range 
from 50% to 70%, and the risks associated with non adherence are extensive at both the 
individual and societal levels [3, 4]. Studies have found that adherence rates lower than 
95% is associated with viral resistance to medications [5, 6]. While adherence to HIV 
therapy has been widely studied in resource rich settings, few studies have addressed 
adherence to HAART in resource constrained settings [7, 8]. Reviews of adherence to 
HIV/AIDS medication have mainly focused on a variety of factors which include 
characteristics of the medication regimen, social factors, psychological factors, patient-
provider relationship, treatment regimen, disease and clinical setting [9, 10]. 
Zambia has a high prevalence of HIV infection. It is estimated that 16% of the 
adult population aged 15 – 49 years is infected and the deaths due to AIDS are estimated 
to 98,000 per year [11]. According to  the Ministry of Health, the number of people 
accessing ART in the last few years has increased over eight fold from 3,000 in 2003 to 
over 47,771 by the end of 2005 [12]. HIV/AIDS treatment is given priority by the 
government [13-15]. In July 2005, the government started providing free treatment to 
people eligible for antiretroviral treatment (ART). This new policy includes free drugs 
and basic laboratory investigations [16]. However, a recent study conducted in one of the 
country’s largest hospitals has raised concern about the emergence of resistant strain to 
the first line ART regimen in Zambia [17]. Little is known about perceived barriers and 
facilitators to ART adherence in Zambia.  
The aim of this study was to explore patients’ and health care professionals’ 






Data were collected during fieldwork in Kitwe and Masaiti districts in the Copperbelt 
Province of Zambia, from August to December 2006. Kitwe is an urban city whereas 
Masaiti is a rural town. We used focus group discussions and in-depth interviews with 
patients on ART, their health care providers and other people who were purposely 
selected on the basis of their experience with ART. Patients were recruited from five 
different health facilities: Three urban (Kitwe Central hospital, Chimwemwe and Ndeke 
Clinics) and two rural (Fiwale and Mishikishi health centres). Recruitment was done by 
health care professionals working in the ART clinics. 
We recruited a sample of patients in their twenties or older with diverse social 
backgrounds and that had been taking medication for different lengths of time. We also 
recruited health care professionals who had experience with ART. Participants gave 
explicit verbal or written consent to participate in the study. All participants were 
informed that they could stop the interview at any point without stating any reason. 
Patients were informed that declining to participate in the study would not affect their 
access to treatment. Participants were given transport re-imbursement of US$ 5. The 
study was approved by the Regional Committee for Research in Norway and the Tropical 
Diseases Research Centre Ethical Committee of Ndola in Zambia. 
 
Interviews 
The first author conducted 22 in-depth interviews and three focus group discussions in 
Kitwe with the help of an assistant. Two focus group discussions in Masaiti district were 
conducted by two research assistants. Semi structured, face to face, tape recorded 
qualitative interviews, and lasting 60 minutes to 120 minutes were conducted by the first 
author and assistants. Of the 72 participants, 42 were interviewed in the hospital setting 
and 30 at a local Non Governmental Organisation’s training centre. The sample size of 72 
participants was a result of data saturation as consecutive interviews yielded diminished 
returns of new information. 
We used interview guides for individual interviews and the focus group 
discussions. The interview guides touched on different aspects of perceived factors that 
influence adherence and non adherence to ART, including how participants perceived 
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HIV/AIDS and ART, their experiences about ART, information on ART, barriers and 
facilitating factors to ART adherence (see Additional file 1). 
 
Analysis 
Audiotapes of the interviews were transcribed in verbatim by the first author and 
assistants. The interviews were translated from Bemba and Lamba, which are local 
languages, into English. All authors read the transcripts from 10 interviews independently 
and developed a coding frame for the analysis. The first author coded all the transcripts, 
and all the authors read independently the material and contributed in negotiating the 
final categories and their contents. Material about participants’ perceived barriers and 
facilitators to ART adherence were identified and used for systematic condensation, by 
applying the phenomenological method of analysis derived from Giorgi [18], and 
modified by Malterud [19]. The analysis followed four steps: (i) reading all the material 
to obtain an overall impression and bracketing previous conceptions; (ii) identifying units 
of meaning representing different aspects of participants’ perceived barriers and 
facilitators to adherence, and coding for these units; (iii) condensing and summarising the 
contents of each of the coded groups; (iv) generalising descriptions and concepts 




We identified several factors that were being perceived as barriers and/or facilitators to 
adherence to ART. We have classified them in three categories: Health services related, 
patient-related, and socio-economic and cultural factors. 
 
Health services related factors 
We found that lack of communication about ART between health care professionals and 
patients and time constraints during consultations were perceived as barriers to 
adherence. Some patients said that they were not informed about how to take their 
medications by their health care providers when they started ART. Many patients 
mentioned the health facility as their most valuable source of information, but for many 
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patients the pharmacy was more important. A 34 year old female patient, widow and 
employed as a teacher explained her experiences: 
 
 “The doctor just writes prescription for collecting drugs. He does not discuss or give 
information on ART. There is no one who has asked me whether I’m taking my drugs or 
not; not even at the pharmacy.” (Participant 7). 
 
Lack of communication about treatment was also recognised by health care professionals 
as a potential barrier, as illustrated in this quote: 
 
“Medicines are usually part of the pharmacy. Because of these changes in the doctors’ 
routine work in the ART clinics, information dissemination to patients has not been so 
good. We encourage them to ask for more information at the pharmacy when they go to 
collect their medications.” (Participant 10, 43 year old female health care professional). 
 
Patients reported that health care providers rushed through their consultations, and as 
such they felt that the information given under such time-constraints could easily be 
misunderstood. Health care professionals on the other hand reported being overwhelmed 
with insufficient time to discuss in detail and assess patients’ concerns and needs that 
might affect ART adherence. They observed that the ever increasing number of patients 
that accessed ART did not match with the number of health care professionals. Almost all 
the health facilities visited did not have a procedure of tracing and managing patients who 
had defaulted from their treatments. A 32 year old male health care professional shared 
his experiences: 
 
“Like at this hospital, we have about 700 patients who have missed their scheduled 
monthly collection of drugs in the last three months. I do not know whether to declare 
them lost or not, but we don’t know what has happened to them.” (Participant 11). 
 
Some health institutions had health care professionals who were not trained in 
counselling but who were involved directly in the ART programmes. The few that have 
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been trained lacked permanent places to conduct counselling. A 31 year old female health 
care professional said: 
 
“We do not have a counselling room. So most of the time we use a small office we call an 
HIV/AIDS Office, but that office is being shared with the Accountant. So it means if I 
have to counsel a patient, that accountant has to leave her work.” (Participant 14). 
 
Most patients and health care professionals from rural areas mentioned long distances 
from the treatment centres as a contributing factor to non adherence. They said that 
patients failed to walk long distances especially when they were too ill. 
 
We found that nutritional support and good information about ART were experienced as 
facilitators to adherence. Nutritional support was mentioned by both patients and health 
care professionals as an important component of ART. Supply of nutritional supplements 
emerged as a facilitator for patients taking ART. A 27 year old female patient, single and 
unemployed said: 
 
“I’m motivated to continue taking my drugs because of the food stuffs the Home Based 
Care Programme offers me. Since I’m not employed, I wouldn’t be managing to feed 
myself.” (Participant 2). 
 
Some patients said that the information they received about ART motivated them to take 
their drugs. This could be information they had been given by health care professionals, 
or from booklets and workshops.  
 
“More knowledge about ART that I receive from workshops motivates me to continue 
taking my drugs.” (Participant 19, 47 year old male patient, married and self employed).  
 
Other facilitators to adherence that were mentioned by patients included free treatment 
and knowing health workers. 
 
 59
Patient related factors 
Forgetfulness and experiencing better health were mentioned as barriers to adherence. 
Several patients mentioned that they forgot to take medication. Some patients forgot their 
medications because of their social lifestyles which interfered with the daily routines of 
taking medication, e.g. excessive alcohol consumption. Others forgot to take their 
medications as a result of pressure or busy work schedules. Some forgot because they 
were living alone, with no one to remind them to take their medication, especially when 
they were very ill. A 34 year old female patient, widow and employed as a teacher said: 
 
“I take my medicines at 0600 hrs and 1800 hrs. Sometimes when I’m tired, I dream too 
much and then wake up later than 0600 hrs, and then I take my medicines like that. I just 
have that worry that maybe my immune system might go down, but that problem is with 
me.” (Participant 7). 
 
Excessive alcohol consumption was mentioned by both patients and health care 
professionals to be contributing to non-adherence. Beliefs about ART were also 
perceived by patients and health care professionals as barriers to taking the drugs. Some 
patients mentioned that ART was a sexual stimulant and that certain patients that did not 
wish to engage in sexual activities therefore decided to stop their treatment. Side effects 
were mentioned by several patients. Some health care professionals believed that side 
effects contributed to patients not adhering to their medications. A 27 year old female 
health worker said:  
 
 “I have this patient who is on the second line treatment who stopped her drugs as a result 
of side effects. She had terrible diarrhoea. She actually confessed that for her she had just 
to stop taking the drugs because the side effects were just unbearable, in the sense that 
she had this diarrhoea and she just didn’t like it; but after so much counselling, I had to 
call in a doctor who talked to her, and we just had to stress to her that if she broke this 
rule now, it was very difficult for us to manage her. So she fortunately did continue and 




Some patients were reported to have stopped taking their medications because they were 
feeling better. Others who stopped taking their medications were said to be overwhelmed 
by ‘pride’, because they were looking physically fit and were back in their healthy, 
functional state. A 37 year old male patient, married and self employed said: 
 
“There is this patient in my neighbourhood. He has stopped taking his medications after 
becoming well. He says that the drugs are too many to be taken everyday in the morning 
and evening as if it is a prayer.” (Focus group interview 5, mixed group). 
 
In contrast, experiencing better health was mentioned many times by both patients and 
health care professionals as a facilitating factor for patients to take their medications 
consistently. Most patients appreciated the benefits of ART in their lives and this 
encouraged them to continue treatment. A 43 year old female health care professional 
shared her experiences: 
 
“I can give an example of one patient who was brought on a stretcher the first day he was 
seen by the doctor. Two weeks later, from the stretcher to a wheelchair, and he could 
stand from the wheelchair to sit on a chair to be seen by the doctor. A month later, that 
patient comes walking on his own. So what motivates them is what they get after starting 
the drugs.” (Participant 10). 
 
Health care professionals and patients observed that many patients were living longer 
than before due to ART. This was seen to motivate patients to continue taking their 
medicines. Many patients said that access to ART was an opportunity to prolong their 
lives, thus, enabling them continue with their caring responsibilities. 
 
Some patients mentioned prayers as facilitators to adherence. Such patients believed that 




Socio-economic and cultural factors 
Stigma, discrimination and disclosure of HIV status, and concerns about confidentiality 
were reported as barriers to adherence. Some patients and health care professionals 
mentioned that stigma was still high in their communities and families despite the 
positive benefits of ART. Some patients were reported to have withdrawn from social life 
as a result of being HIV positive. Disclosure of one’s status and taking ART had negative 
consequences in many patients’ lives. Most patients said that they could not disclose their 
status for fear of being victimised, rejected or accused of infidelity. Because of the 
traumatic nature of such experiences, some patients have ended up not adhering to their 
medications, as explained in this quote by a 27 year old female health care professional: 
 
 “I have one client who is HIV positive and has disclosed to her husband. The husband 
has been negative about it and it has been affecting her. She has been non compliant with 
her medications and she has been in and out of the hospital ward. We just have to keep on 
talking to her. Each time her relatives come in, they are pleading, can you please talk to 
our sister.” (Participant 12). 
 
Many patients expressed concerns about confidentiality in the treatment centres, 
especially in the pharmacies where they collected their medications. The affected patients 
felt unsafe or uncomfortable with accessing their medications at the pharmacies. A 35 
year old female patient, married and a businesswoman explained: 
 
“The current place they use to dispense ARVs is next to the main pharmacy and many 
people have come to know that. There is also a nutrition office on the other side. Some 
patients shun sitting on the bench and opt to go and stand somewhere else and wait for 
the people to finish before they can collect their drugs. I have seen this myself. This 
treatment has just come and people are not yet used to such.” (Participant 8).  
 
Some patients mentioned that they experienced difficulties in explaining their illnesses 
properly to their doctors because of poor confidentiality. 
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“We are seen in the same room with other general cases. Most of the times we are found 
in situations where you are two patients in the same room and that becomes very difficult 
to explain properly about your illness when there is a stranger.” (Participant 6, 33 year 
old female patient, married and a housewife) 
 
The use of alternative treatments was perceived by patients and health care professionals 
as a barrier to ART adherence. They observed that patients stopped taking their ART and 
concentrated on traditional medicines or other spiritual rituals. Lack of food was 
perceived as a barrier to ART adherence.  
Many patients interviewed believed that ART cannot be taken without food. 
Despite being regarded by many as an important barrier to adherence, several patients 
and health care professionals mentioned self disclosure as a critical facilitator, usually 
linked to the support they received from their families. A 47 year old male patient, 
married and self employed shared his experiences: 
 
“I have disclosed my status to my wife and children. They have accepted my situation 
and are very supportive. Even when I’m busy with work, they remind me to take the 
medicines.” (Focus group 1, male group). 
 
Some patients and health care professionals stated that certain patients who belonged to 
support groups which had income generating activities were motivated to continue with 
their medicines because of the support they received from such groups. A 38 year old 
male patient, married and a peasant farmer said: 
 
 “Our support group runs a grocery and a hammer mill. Part of the money we generate 
assists us to support ourselves. This has motivated many of us to continue with our 
treatments.” (Focus group 4, male group). 
 
Some patients who were registered and supported by NGOs mentioned the transport 
support they received each time they went for their medical reviews as a facilitator for 




Validity and transferability 
We have explored perceived barriers and facilitators to ART in a sample of patients, 
health care professionals, and other informants. We think our results may be valid and 
transferable to other settings in Zambia, though we can not determine to what extent 
different factors are barriers or facilitators in a given context. A strength of this study is 
that the results can however be used to understand the many different factors that may 
influence adherence to ART. We recruited participants from the ART clinics and were all 
taking medication or providing a service in the ART clinic. Interview guides were pre-
tested in order to check for clarity of questions, questioning techniques and establishment 
of rapport. The interviewees were given enough time to elaborate their answers and 
consistency of information was checked by paraphrasing what the interviewees said. To 
minimize bias, after the interviewers transcribed and translated the interviews, an 
independent transcriber and translator went through the transcriptions as an effort to 
strengthen the data by independently listening to the interview tapes and compare with 
the transcribed interviews for possible misinterpretations. The interviewers considered 
suggestions made in the final transcripts. Another strategy used to strengthen the data was 
the use of different sources of information. Data collected from patients and health care 
professionals from both urban and rural was supplemented by data collected from other 
informants. 
This study provides an overview of perceived barriers and facilitators to 
antiretroviral therapy in Zambia. Our study found barriers and facilitators which were 
diverse in nature and belonged to a wide spectrum of factors which include patient 
related, health service related, socio-economic and cultural factors. These include lack of 
communication and information about ART, inadequate time during consultations, follow 
up and counselling, forgetfulness, stigma, discrimination and disclosure of HIV status, 
lack of confidentiality in the treatment centres, lack of nutritional support, feeling better, 
prospects of living longer, family support, information about ART, support for income 
generating activities and transport. 
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Improved health as an ambiguous factor 
One striking result was that of feeling better, which could be a barrier as well as a   
facilitator to ART adherence. Patients were reported to stop taking their medications 
when they felt better. On the other hand, patients and health care professionals mentioned 
that patients were motivated to continue taking their medications because of feeling better 
as a result of ART. Improvement of subjective health has to be understood in the context 
of patients’ beliefs about the treatment and how well informed they are. Some patients 
believed that they were healed and therefore could not understand why they should 
continue taking medication. While a number of patients and health care professionals said 
that adherence counselling to patients was offered at the start of their treatment, the 
emerging scenario suggests a new approach to counselling. The stage of treatment when 
the patient is feeling better can be a critical turning point for patient adherence. Thus, it 
seems logical that adherence counselling should focus in particular on patients during this 
phase of treatment. Also earlier studies have reported feeling better as either a barrier or 
facilitator to adherence [20, 21]. 
 
Communication and information about medication 
Lack of communication and information about ART emerged as a barrier to adherence in 
our study. Most patients and some health care professionals mentioned that patients 
received little or no information about their medications from their health care providers. 
Other studies have also found that poor or lack of communication was a barrier to 
adherence to ART [22]. Most patients also mentioned their health facilities as their major 
source of information about their treatments. In the hospital-setting patients and some 
health care professionals stated that such information was provided at the pharmacies and 
not during consultations with doctors. Patient-provider communication has been shown to 
potentially facilitate adherence. Patients who receive adequate information about their 
treatment regimens were more likely than others to comply with medical advice [23, 24]. 
 
Confidentiality 
Another issue that emerged from the study was that of confidentiality in the treatment 
centres especially at the pharmacies. While the pharmacies were used as information 
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dissemination centres for ART adherence, most patients did not favour that approach. In 
some health facilities, the pharmacy for dispensing ART was different from the general 
pharmacy, which made patients feel labelled by their health institutions. This illustrates 
the importance of taking confidentiality and stigma issues into consideration when the 
provision of ART is being scaled up. 
 
Stigma 
Some patients and health care professionals mentioned that stigma was still rife in their 
families and communities. Stigma has been highlighted in other studies as a barrier to 
ART adherence [25, 26] and it has been demonstrated that fear of disclosure of 
HIV/AIDS status or being noticed taking medication can contribute to patients not 
adhering to their medications[27, 28]. However, while disclosing one’s HIV status was 
mentioned as a barrier by some patients in our study, for others, disclosure was said to 
facilitate adherence to ART. They were motivated to continue taking their medications 
because of the strong support they received from their spouses, families and 
communities.   
 
Nutritional support 
Nutritional support emerged as a critical factor for ART adherence. Lack of food was 
mentioned by both patients and health care professionals as a contributing factor to non 
adherence to ART while nutritional support was mentioned as a facilitator. However, 
most of the health facilities did not provide any nutritional support to their patients on 
ART. Lack of food has been identified before in some studies as a factor responsible for 




In this study we have identified the multiplicity of factors and issues that need to be taken 
into consideration when providing ART. Further research is needed, including participant 
observations, to capture the actual interactions between patients and their health care 
providers. Also, future studies should assess the magnitude of non adherence to ART in 
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Zambia using quantitative measures. Our findings can inform the design of interventions 
to promote adherence to ART. However, the complexity of factors acting as barriers 
and/or facilitators to treatment adherence imply that the effectiveness of such 
interventions are unpredictable and need to be evaluated rigorously, preferably in 
randomised controlled trials. 
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Age, years   
20 – 29 17  
30 – 39 33 
40 – 49 10 
Gender   
Men 33 
Women 27 
Urban Participants  40  
Rural Participants 20 
Taking ART 0 – 12 months 37 
Taking ART over 12 months 23 
Occupation   
Professionals 2 
Self - employed 30 
Unemployed 28 





0 – 7 Grades  30 
8 – 12 Grades  25 
College/University Level 5 
  
Health care professionals 12 
 72
Age, years    
20 – 29 2 
30 – 39 7 
40 – 49 3 
Gender  































Table 2. List of barriers and facilitators to adherence to antiretroviral treatment 
 Barrier Facilitator 
Health service related Lack of communication about 
treatment 
Nutritional support 
 Time constraint Knowing health care professionals 
 Language barrier Information about ART 
 Lack of information about ART Government policy of free ART 
 Poor staff competences  
 Lack of patient follow up  
 Inadequate counselling  
 Long distance to treatment centres  
 Lack of confidentiality  
   
Patient related Side effects Feeling better 
 Pill burden Prospects of living longer 
 Beliefs about ART Prayers 
 Forgetfulness  
 Excessive alcohol consumption 
Feeling better 
 
   
Socio-economic and 
cultural 
Lack of emotional/psychological 
support 
Family support 
 Lack of food Support programmes for income 
generating activities 
 Lack of disclosure of status Disclosure of status 
 Stigma and discrimination Free transport 










CHAPTER 5: RECOMMENDATIONS 
 
This study has explored factors that influence adherence to ART in a sample of patients, 
health care professionals and other informants and I think the results may be valid and 
transferable to other settings in Zambia, though I cannot determine to what extent 
different factors influence adherence to ART in a given context. A strength of this study 
is that the results can however be used to understand the many different factors that may 
influence adherence to ART.  
There is need for intervention and quantitative studies in future in this setting, and I so far 
suggest some recommendations: 
 
1. Recommendations to Government and policy makers 
 
I) My study found that patients had trouble with understanding information material and 
that available material was often written in English only. For some patients language was 
a barrier. I therefore recommend that the Ministry of health take measures to improve 
health education materials, both in English and local language, aimed at patients 
diagnosed with HIV and AIDS. 
 
II) Participants in this study reported that most health facilities lacked room for activities 
such as counselling, consultations, laboratory and dispensing. Health care professionals 
reported this as a barrier to adherence. I therefore recommend that the Ministry of health 
advocates investment in infrastructure development in order to meet the demands of 
scaling up ART services. 
 
III) This study suggests that if patients have to take large quantities of drugs each day, 
this may be a barrier to adherence to ART. In order to improve adherence, i suggest that 
the Ministry of health should advocate government to lobby donors to help purchase 
fixed dose combinations of ART. 
 
IV) In this study, it was found that nutrition support was perceived as a facilitating factor 
to ART adherence, while lack of food was perceived as a barrier to ART adherence. I 
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therefore suggest that the Ministry of health and NGOs should advocate government to 
introduce a policy that incorporates nutrition in the treatment package. 
 
V) This study found that long distances from health facilities were reported as a barrier to 
adherence, especially in the rural areas. It is therefore suggested that government should 
increase the number of sites offering ART as a way of working towards achieving the 
vision of the health reforms of bringing health services as close to the family as possible. 
 
2. Recommendations to the health care system (Implementing institutions) 
 
I) Lack of competence in staff was perceived as a barrier to ART adherence by both 
patients and health care professionals. This would suggest the need to train health care 
professionals in counselling and ART management. 
 
II) Availability of information and education materials was perceived as a facilitator to 
ART by patients and other people interviewed. This therefore suggests that the health 
facilities should provide such materials to patients and their supporters regularly. These 
materials could be much more helpful if they were available in local languages. 
 
III) My study found that patient-provider interaction and information giving was almost 
non existent. Lack of communication was perceived by patients and some health care 
professionals as a barrier to ART adherence, while some patients mentioned knowing 
health care professionals as a facilitating factor to ART adherence. This suggests that 
patient education and counselling should be improved or encouraged. 
 
IV) Lack of confidentiality at treatment centres was perceived by patients as a barrier to 
ART adherence. It therefore appears that improving working environment in health care 
settings may ensure confidentiality during consultations, waiting times and when 
collecting medicines at the pharmacies. 
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V) This study found that most health facilities did not have patient monitoring and follow 
up system. That led to some health facilities losing considerable numbers of patients. I 
therefore recommend that health facilities should establish patient monitoring and follow 
up systems. 
 
VI) Collaboration between health care systems and other stakeholders supporting ART 
programmes was found not to be well streamlined. Good collaboration has potential to 
foster patient tracking and follow up. I therefore recommend defined collaboration among 
all stakeholders in the ART programme. 
 
VII) Stigma was still rife in families and communities, and i also found that some health 
facilities had separate dispensing outlets or pharmacies for ART. Stigma was perceived to 
be a barrier to ART adherence, and i therefore suggest that ART services should be 
integrated into the general health services as this may reduce stigma and increase the 
uptake of ART services. 
 
3. Recommendations to patients and the community 
 
I) This study found that lack of human resources was perceived as a barrier to ART 
adherence programmes. This therefore appeals for consideration to train community lay 
people in counselling so that they may help with patient support in the communities. 
 
II) In this study, i found that stigma was still high in families and communities. 
HIV/AIDS and ART education campaigns may reduce stigma in communities and may 
also lead to decreased discrimination of individuals with HIV/AIDS and ART. 
 
III) Family and community support emerged as a facilitating factor to ART adherence in 
this study. I therefore suggest that families and communities should be encouraged to 
form support groups focussed on ART to help with adherence strategies of coping with 
chronic illnesses.  
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IV) This study found that patients feared to disclose their HIV-status to their spouses, 
families, friends and communities for fear of rejection and victimization. This suggests 
that empowering patients with skills in disclosure counselling may help them in 
negotiating their life situations in their relationships, families and communities. 
 
V) Income generating activities were perceived as a facilitator to ART adherence and 
lack of food and other nutritional supplements was perceived as a barrier to ART 
adherence. This suggests that supporting patients engage in income generating activities 
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Appendix 1: In-depth Interview Guide for ART Patients 
 
Interview no ---------------              Location --------------- 
 
Introduction: All the interviews will start with thanking the participant for participating 
in the study. Explain the purpose of the interview, make the respondent relaxed, assure 
confidentiality of information they provide and thank them for their time. Make them feel 
that the information they are going to provide is important for the furtherance of the study 
objectives. Show the participant the information letter or read it to them if they are 
illiterate. Both the participant and the researcher should sign the informed consent form, 
or oral consent is given on a tape recorder if the respondent is illiterate. In the case where 
a translator is used, explain to the participant the role of the translator and the role of the 
researcher. Ask the participant for their approval to use a tape recorder to record the 
interview and/ or for taking notes throughout the interview. 
1. Socio – Demographic Information 
a) How old are you? 
b) How long have you been living around here? (Where did you live before?) 
c) Do you have any education? 
d) What do you do or have done for your living? 
e) Are you married? 
f) Do you have children? 
g) What is the distance from where you live to the clinic? 
 
2.  Service Factors 
a) Please tell me more about your experiences with finding help to receive ART at your 
health facility 
    Probe for: 
• Handiness of the health facility to meeting the ART needs of patients 
• Relationship between health workers and patients 
• Availability of drugs 
• Availability of health workers 
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• Infrastructure availability 
 
3.  Knowledge, Perceptions and Beliefs about HIV/AIDS and ART 
 a)  Please tell me more about HIV/AIDS and ART 
    Probe for: 
• Difference between HIV and AIDS 
• When to start treatment 
• Difference between CD4 count and Viral load 
• Relationship between adherence and viral load 
• Type of medication being taken 
• Knowledge about side effects of drugs 
• Duration of taking medication 
a) In your opinion, are there any beliefs that you feel may influence the pattern of 
your taking ART? 
b) (Re-assure the patient of confidentiality) Tell me more about what you know about 
being on ART and your sexual life. 
c) Tell me too about what you know about being on Art and taking alcohol 
d) From your experience, how do people handle issues of disclosing their status of 
taking ARVs to their partners? 
e)  
4. Information on ART and Adherence 
a) Where have you received information about how to use your medication? 
b) Has anyone told you or have you read what may happen if you do not take your 
medication according to the health professionals’ instructions? 
c) How has the information you have received about ART affected your life on 
ART? 
d) In your opinion, what do you think should be done to improve the level of ART 
adherence? 
e) How would you describe the information offered by health workers in the ART 
Programme to patient’s lifelong needs of adherence? 
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5. Barriers and Motivating factors to adherence to ART 
    a)  According to your experience, do you know any patients who do not take their                         
medications as prescribed and why?         
   b)     In your opinion, why may patients not come back for their monthly visits? 
   c)     What do you think can motivate patients to come back for their monthly visits? 
   d)    What sort of assistance do you receive from health workers to help you manage 
ART? 
   e)    What could be improved in the health facility you use? 
 
NB. Thank the participants for their efforts and contributions during the interviews. Do a 
recap of what was discussed with the participants so that they can verify the information.  


















Appendix 2: In-depth Interview Guide for Health Care Professionals 
 
 
Interview no ---------                           Location ----------------- 
 
Introduction: All the interviews will start by thanking the person for participating in the 
study. Explain the purpose of the interview, make the respondent relaxed, assure 
confidentiality of information they provide and thank them for their time. Make them feel 
that the information they are going to provide is important for the furtherance of the study 
objectives. Show the participant the information letter. Both the participant and the 
researcher should sign the informed consent form. Ask the participant for their approval 
to tape record the interview or taking notes throughout the interview. 
1. Socio – Demographic Information 
a) How old are you? 
b) How long have you been working around here? 
c) What is your occupation? 
d) What is your education? 
e) Are you married? 
2. Service Factors 
f) Tell me more about how ART programme is coordinated at your health facility: 
Probe for: 
• Staffing levels and responsibilities 
• Infrastructure 
• Handiness of the facility to meet the needs of ART patients 
• Motivation 
 
3. Knowledge, Perception and Beliefs about ART. 
a) Please tell me more about ART: 
      Probe for: 
• National policy on ART 
• Current treatment guidelines 
• Availability of adherence policy or guidelines 
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• Concept of adherence 
b) What do you know about ART? 
c) How does it work around here? 
d) How do people deal with HIV/AIDS in this area? 
 
4. Information on ART and Adherence 
a) How do you tell ART patients how they should use their medication and do you 
tell them what might happen if they do not follow instructions? 
b) What do you tell patients about how they should use their medications? 
c) Do you have any written patient information? 
d) In your opinion, what do you think should be done to improve the level of 
adherence to ART among the patients? 
5. Barriers and motivating factors to adherence to ART 
a) According to your experience, do you know any patient(s) who do not take their 
medications as prescribed and why? 
b) Do some patients not turn up for their monthly visits? What do you think are 
possible reasons for this? 
c) What do you think motivates patients to take their medications as prescribed in this 
setting? 
d) What are the barriers to patients taking their medications as prescribed, from your 
experience? 
e) How do you address the treatment plan for patients who do not take their 
medications as prescribed at your health facility? 
 
NB. Thank the participants for their efforts and contributions during the interviews. Do a 
recap of what was discussed with the participants so that they can verify the information.  













I ………………………………………..pledge that I understand the purpose of this study 
and that I will never use the information gathered through this study for my own interests 
or breach the confidentiality of any of the participants who will take part in this study at 
any time without the knowledge of the Principal Investigator. 
 
 
……………………………….                                                    ……….. 
Signature of Research Assistant                                                  Date 
 
 
………………………………                                                      ……….. 
Signature of Witness                                                                    Date 
 
 
……………………………….                                                    ………… 












Appendix 4: Participant Information Sheet and Consent Form 
 
Iam a student from the University of Oslo in Norway studying International Community 
Health. Iam interested in issues that may help improve adherence to antiretroviral 
treatment in Zambia, with a six month fieldwork in Zambia from July until December, 
2006. The aim of this study is to gain knowledge about adherence to antiretroviral 
treatment in Zambia, in order to identify interventions that may be efficient in increasing 
patient’s adherence to antiretroviral treatment. 
Iam interested in what you know and your experiences with antiretroviral treatment. I 
will conduct an interview with you about this. I will ask for your permission to tape 
record the interview so that it helps me capture accurately your insights in your own 
words. The tapes will only be heard by me alone for the purposes of this study. You may 
ask the tape recorder to be turned off at anytime. The information you provide will be 
treated confidentially and shall not be used for any other purpose other than the 
production of the report. Your name will not be used at any point.  
If you do not wish to participate in the study, this will not affect your ability to access the 
usual services you currently receive or expect to get from your health provider now and 
in future. The interview is expected to take about 45 minutes. For those who participate 
in group discussions, the expected time is one hour and thirty minutes. Any questions you 
have about this study can be directed at the researcher (see contact details below). A 
summary of preliminary results can be provided at your request. The final results of the 
study will be shared with the Ministry of health, Network of Zambian People Living with 
HIV/AIDS, Non Governmental Organizations and Community Based Organizations 
represented in the study. The results may also be used in further studies or as a 
contribution to the body of knowledge on factors affecting adherence to antiretroviral 
treatment in Zambia. 
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Jan C. Frich 
Department of General Practice and Community Medicine 
University of Oslo 
Norway 
j.c.d.frich@medisin.uio.no 
Co – Supervisor 
Atle Fretheim 





Consent (Statement of declaration): 
I understand the purpose of this study and have accepted to participate from my own 
accord, without being forced to do so. 
 








































Appendix 10: Amended application letter from TDRC 
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